About ubs-ch

This author has not yet filled in any details.
So far ubs-ch has created 398 blog entries.

Weekly-Hits edition of 26.10.2018

KeyInvest Weekly Hits

Friday, 26.10.2018

  • Topic 1: Low-volatility strategy - Get off the roller coaster
  • Topic 2: Gold - The crisis currency moves up

Low-volatility strategy
Get off the roller coaster

Trade disputes, Brexit chaos and a controversial Italian budget proposal – these three factors have been making life uncomfortable for investors recently. They have also caused the turbulence on the global equity markets to rise sharply. Collective sentiment is reflected in implied volatilities. The range of fluctuation priced into options shot up at the start of the fourth quarter (see chart). In an environment like this, investment strategies targeting stocks with relatively low volatility could come into their own once again. The same goes for the K Switzerland Low Volatility NTR Index. Year to date this underlying has extended its long-term outperformance of the SMITM.1 A PERLES (symbol: SOLVZU) can give investors exposure to this benchmark in their portfolio.

Performance on the Swiss equity market is something of a roller coaster at the moment. The SMITM gained 5.6% between July and September 2018. This was the strongest performance the domestic blue chip index had posted since the first three months of 2013. But it was not enough for a breakout to the upside. Instead, recent weeks have seen the SMITM move down smartly. Shortly before the end of October the performance for the month was down 3.5%.1 Over extended periods these ups and downs in prices reduce returns. Academic studies have demonstrated that portfolios of relatively low-volatility stocks beat the broader market in the long term. This puts them at odds with traditional capital market theory, which assumes that the more risk an investor takes, the higher the return on a diversified portfolio. Robert Haugen and James Heins documented the “low volatility anomaly” as long ago as 1972. Twenty years after that, US researchers Eugene Fama and Kenneth French published a three-factor model. One of the characteristics this featured as driving returns was low volatility.

This is the starting point for the K Switzerland Low Volatility Index. The benchmark is based on smart beta methodology. In other words, the composition of the index does not weight the constituent stocks by market capitalization in the traditional way. Instead, it implements a low-volatility strategy in the Swiss equity market. Candidates for inclusion come from the 300 companies with the largest capitalization. Every month a filter selects the 20 stocks with the lowest range of price fluctuations from this universe. Weightings are based on inverse volatility, so the less a stock price moves compared to the other index constituents, the higher its percentage. The weighting of a single component is capped at 10% to avoid cluster risk.
The current composition of the K Switzerland Low Volatility Index reflects the full range of the domestic equity market: there are nine stocks in the SMITM and 11 second and third-liners. These include several shares which have been little affected by the recent market turbulence. Helvetia Holding, PSP Swiss Property and Lindt & Sprüngli, for example, have risen year to date¹.

Opportunities: The PERLES is listed on SIX (symbol: SOLVZU) and is a way of taking a diversified position in the 20 lowest-volatility stocks on the Swiss equity market. The product replicates the K Switzerland Low Volatility Index for an annual management fee of 1.00%. Any dividends on the constituents are reinvested net in the underlying. The term is limited to a total of seven years, but this can be extended by the same period.

Risks: This product does not have capital protection. With a PERLES, losses are incurred if the underlying index falls. Investors in structured products are also exposed to issuer risk, which means that the capital invested may be lost if UBS AG becomes insolvent, regardless of the performance of the underlying.

More UBS products and further information on the risks and opportunities are available at ubs.com/keyinvest.

K Switzerland Low Volatility NTR Index vs. SMI™ TR Index
(5 years; for illustrative purposes only; figures in %)¹

The K Switzerland Low Volatility Index has risen in the past. Over a five-year period the smart beta benchmark has outperformed the SMITM considerably.

Source: UBS AG, Bloomberg

As of 25.10.2018

Helvetia Holding vs. Lindt & Sprüngli vs. PSP Swiss Property
(5 years; for illustrative purposes only; figures in %)¹

Insurance, chocolate and real estate are the industries Helvetia, Lindt & Sprüngli and PSP operate in, all of which have contributed to the recent outperformance of the K Switzerland Low Volatility Index.

Source: UBS AG, Bloomberg

As of: 25.10.2018

¹) Please be aware that past performance does not indicate future results.
²) The conditions of ETTs are reviewed on a yearly basis and can be adjusted with a deadline of 13 months after the announcement.

PERLES on the K Switzerland Low Volatility Index

Symbol SOLVZU
SVSP Name Tracker-Certifikat
SPVSP Code 1300
Underlying K Switzerland Low Volatility Index
Ratio 1:1
Currency CHF
Administration fee 1.00% p.a.
Participation 100%
Expiry 17.04.20123
Issuer UBS AG, London
Bid/Ask CHF 251.25 / 252.75
 

K Switzerland Low Volatility Index – Composition as of 31.08.2018

Helvetia PSP Swiss Property
Baloise Swiss Prime Site
Nestlé Swiss Re
Kuehne & Nagel Swiss LIfe
Swisscom SGS
Lindt & Sprüngli Schindler Holding
Geberit Roche Holding
Givaudan EMS Chemie
Partners Group Barry Callebaut
Zurich Insurance Pargesa Holding
 

More UBS products and further information on the risks and opportunities are available at ubs.com/keyinvest.

Source: UBS AG, Bloomberg

As of: 25.10.2018

Market overview

Index Quotation Week¹
SMI™ 8’724.61 -0.3%
SLI™ 1’358.59 -2.9%
S&P 500™ 2’656.10 -5.5%
Euro STOXX 50™ 3’130.33 -3.5%
S&P™ BRIC 40 3’744.33 -3.2%
CMCI™ Compos. 949.39 -1.6%
Gold (troy ounce) 1’231.10 USD 0.3%

¹ Change based on the closing price of the previous day compared to the closing price a week ago.

SMI™ vs. VSMI™ 1 year

smi vs vsmi

The VSMI™ Index is calculated since 2005. It shows the volatility of the stocks within the SMI™ index. A portfolio which reacts only to changes in volatility instead of volatility itself is relevant for the calculation. Thereby, the VSMI™ methodology uses the squared volatility, known as variance, of the SMI options with remaining time to expiry of 30 days traded at the Eurex.

Source: UBS AG, Bloomberg

As of: 25.10.2018

Gold
The crisis currency moves up

The weather may have been nice in October, but things were less agreeable on the stock market. As discussed on the preceding pages, equity market corrections pushed volatility up sharply. At the same time, gold showed signs of life. The crisis currency has risen 3.4% since the end of September.¹ Logically, the ETC (Symbol: CGCCIU) on the UBS Bloomberg CMCI Gold CHF Monthly Hedged TR Index broke out to the upside of its downward technical trend. This participation product makes it possible to take roll-optimized positions in the precious metal.

Most investor showed little interest in gold as a safe haven until the end of the third quarter. The steep increase in interest rates in the USA and the associated strength of the dollar weighed on it in particular. While the greenback itself remains in demand as a crisis currency and is holding up at a high level, the gold price has shot up in recent weeks. Clearly the rise in general uncertainty factors has driven increasing numbers of investors to switch to risk-off mode. The situation in Italy is of special concern for financial markets. The government of the right-wing Lega party and the populist Five Star movement is planning to raise far more new debt in 2019 than its predecessor had indicated. The EU Commission has rejected Rome’s draft proposal, something which has never happened before in the history of the Eurozone. “If trust is eroded, all Member States take damage, our union takes damage,” said Commission Vice-President Valdis Dombrovskis of this unprecedented step. Italy now has three weeks to react to the criticism and submit a new budget for 2019 to Brussels. (Source: Thomson Reuters media report, 23 October 2018)

Opportunities: The ETC (Symbol: CGCCIU) on the UBS Bloomberg CMCI Gold CHF Monthly Hedged TR Index allows investors to diversify their portfolios simply and cheaply. The product underlying replicates the gold price by using various futures contracts. As is typical for the CMCI index family, positions are taken across the entire forward curve and all liquid maturities. A hedging mechanism ensures that fluctuations between the US dollar (the currency gold is priced in) and the Swiss franc (the product currency) are neutralized every month.

Risks: This product does not have capital protection. With an ETC, losses are incurred if the underlying index falls. Investors in structured products are also exposed to issuer risk, which means that the capital invested may be lost if UBS AG becomes insolvent, regardless of the performance of the underlying.

More UBS products and further information on the risks and opportunities are available at ubs.com/keyinvest.

Gold (in US dollars per fine ounce) 5 years¹

Source: UBS AG, Bloomberg

As of: 25.10.2018

ETC on the UBS Bloomberg CMCI Gold CHF Monthly Hedged TR Index

Symbol CGCCIU
SVSP Name Tracker-Certifikat
SPVSP Code 1300
Underlyings UBS Bloomberg CMCI Gold Monthly Hedged TR Index
Currency CHF
Ratio 10:1
Administration fee 0.38% p.a.
Participation 100%
Expiry Open End
Issuer UBS AG, London
Bid/Ask CHF 74.75 / 75.10
 

More UBS products and further information on the risks and opportunities are available at ubs.com/keyinvest.

Source: UBS AG, Bloomberg

As of: 25.10.2018

¹) Please be aware that past performance does not indicate future results.
²) The conditions of ETTs are reviewed on a yearly basis and can be adjusted with a deadline of 13 months after the announcement.

This material has been prepared by UBS AG or one of its affiliates («UBS»). This material is for distribution only as permitted by law. It is not prepared for the needs of any specific recipient. It is published solely for information and is not a solicitation or offer to buy or sell any securities or related financial instruments (“Instruments”). UBS makes no representation or warranty, either express or implied, on the completeness or reliability of the information contained in this document (“Information”) except that concerning UBS AG and its affiliates. The Information should not be regarded by recipients as a substitute for using their own judgment. Any opinions expressed in this material may change without notice and may be contrary to opinions expressed by other business areas of UBS as a result of using different assumptions or criteria. UBS is under no obligation to update the Information. UBS, its officers, employees or clients may have or have had an interest in the Instruments and may at any time transact in them. UBS may have or have had a relationship with entities referred to in the Information. Neither UBS nor any of its affiliates, or their officers or employees, accepts any liability for any loss arising from use of the Information. This presentation is not a basis for entering into a transaction. Any transaction between you and UBS will be subject to the detailed provisions of the term sheet, confirmation or electronic matching systems relating to that transaction. Clients wishing to effect transactions should contact their local sales representative.
This information is communicated by UBS AG and/or its affiliates («UBS»). * (see below) UBS may from time to time, as principal or agent, have positions in, or may buy or sell, or make a market in any securities, currencies, financial instruments or other assets underlying the product to which this website relates (the «Structured Product»). UBS may provide investment banking and other services to and/or have officers who serve as directors of the companies referred to in this website. UBS’s trading and/or hedging activities related to the Structured Product may have an impact on the price of the underlying asset and may affect the likelihood that any relevant barrier or relevant trigger event is crossed or triggered. UBS has policies and procedures designed to minimise the risk that officers and employees are influenced by any conflicting interest or duty and that confidential information is improperly disclosed or made available. UBS may pay or receive brokerage or retrocession fees in connection with the Structured Product described herein. In respect of any Structured Product that is a security, UBS may, in certain circumstances, sell the Structured Product to dealers and other financial institutions at a discount to the issue price or rebate to them for their own account some proportion of the issue price. Further information is available on request. Structured Products are complex and may involve a high risk of loss. Prior to purchasing the Structured Product you should consult with your own legal, regulatory, tax, financial and accounting advisors to the extent you consider it necessary, and make your own investment, hedging and trading decisions (including decisions regarding the suitability of the Structured Product) based upon your own judgement and advice from those advisers you consider necessary. Save as otherwise expressly agreed in writing, UBS is not acting as your financial adviser or fiduciary in relation to the Product. UBS generally hedges its exposure to Structured Products, although it may elect not to hedge or to partially hedge any Structured Product. UBS’s hedging activity may be conducted through transactions in the underlying asset, index or instrument or in options, futures or other derivatives related to the underlying asset, index or instrument on publicly traded markets or otherwise, and may have an impact on the price of the under-lying asset. If a transaction is cash settled, UBS will generally unwind or offset any hedge it has for such Structured Product in close proximity to the relevant valuation time or period. In some cases, this activity may affect the value of the Structured Product. Unless stated otherwise in this document, (i) this document is for information purposes only and should not be construed as an offer, personal recommendation or solicitation to purchase the Structured Product and should not be treated as giving investment advice, and (ii) the terms of any investment in the Structured Product will be exclusively subject to the detailed provisions, including risk considerations, contained in the more detailed legal documentation that relates to the Structured Product (being the confirmation, information memorandum, prospectus or other issuer documentation as relevant). UBS makes no representation or warranty relating to any information herein which is derived from independent sources. This document shall not be copied or reproduced without UBS’s prior written permission. In respect of any Structured Product that is a security, no action has been or will be taken in any jurisdiction that would permit a public offering of the Product, save where explicitly stated in the issuer documentation. The Structured Product must be sold in accordance with all applicable selling restrictions in the jurisdictions in which it is sold.
© UBS 2018. All rights reserved. UBS prohibits the forwarding of this information without the approval of UBS.
Weekly-Hits edition of 26.10.20182018-10-26T09:07:07+02:00

Weekly-Hits édition de 19.10.2018

KeyInvest Weekly Hits

Vendredi, 19.10.2018

  • Thème 1: Actions du secteur des puces et semi-conducteurs - La liquidation comme opportunité d’entrée
  • Thème 2: BMW/Tesla - Un constructeur Premium au courant

Actions du secteur des puces et semi-conducteurs
La liquidation comme opportunité d’entrée

On a récemment observé une véritable liquidation pour les actions du secteur des puces et semi-conducteurs. L’indice des semi-conducteurs de la bourse de Philadelphie a plongé de plus de 4% en une semaine. Infineon, le titre du DAX, a encore souffert davantage puisqu’il a perdu environ le double sur la même période. On trouve aussi depuis un certain temps sur la liste des ventes des courtiers en valeurs mobilières AMS, le spécialiste des puces qui a même perdu, sur un mois, plus du quart de sa capitalisation de marché.¹ Après les ventes générales dans le secteur, il pourrait être tout à fait judicieux de réfléchir à une entrée, compte tenu du faible niveau des cours. Au vu des incertitudes boursières, il ne faudra toutefois pas renoncer à une protection partielle sous condition. Le Double Coupon Kick-In GOAL (symbole : KCRRDU) sur AMS, Infineon et Intel actuellement en souscription présente des conditions intéressantes. Outre une marge de sécurité de 40% et un coupon de 10% p.a., le produit offre aussi l’opportunité supplémentaire de doubler le rendement. Pour ceux qui préféreraient ne miser que sur un sous-jacent, nous recommandons de considérer l’Early Redemption Kick-In GOAL (symbole : KCSEDU) sur AMS. En seulement deux ans, une rémunération de 10.00% p.a. est ainsi possible.

Même si actuellement les entreprises de semi-conducteurs subissent de fortes fluctuations en bourse, le secteur reste sur la voie de la croissance. Selon les experts d’IC Insights, le marché mondial des puces devrait progresser de 14% à 509.1 milliards de dollars US pour l’année en cours, et dépasser ainsi pour la première fois le seuil du demi-billion de dollars US. Au vu des nouvelles tendances technologiques telles que le Big Data, l’Internet des objets (IoT) ou l’intelligence artificielle, la demande de puces devrait rester forte. IC Insights estime que la part des semi-producteurs aux produits électroniques devrait passer de 28.8% en 2017 à 31.5% en 2022. (Source : IC Insights, 18.07.2018)

Selon les analystes de CIO WM, la saine demande de semi-conducteurs se reflète déjà dans l’évolution des grands de la branche. En conséquence, les experts ont actuellement classé le secteur comme « neutre ». Ils soulignent Intel comme leur entreprise préférée. Le géant des puces participe notamment vigoureusement aux tendances d’avenir Data-Center et IoT. Ces deux segments ont progressé au deuxième trimestre de 27 et 22% ce qui vaut la peine d’être remarqué. Pour l’exercice en cours, Intel prévoit un chiffre d’affaires record pour la troisième fois consécutive.
Pour Infineon également, les signaux indiquent toujours la croissance. Suite aux récentes secousses de cours, les Allemands confirment leurs objectifs de croissance pour 2018/19 (30 septembre). « Nous ne voyons aucune raison de remettre en question les perspectives », a déclaré un porte-parole de la société (source : Thomson Reuters, communiqué de presse, 10.10.2019). Le groupe prévoit une hausse de 10% de son chiffre d’affaires. La société autrichienne AMS, connue surtout comme fournisseur d’Apple, connaît également une forte croissance, mais subit actuellement une pression sur les marges. Même si UBS IB Research considère qu’il existe des opportunités pour AMS dans la sensorique 3D, les experts classent le titre comme « neutre » avec un objectif de cours réduit à 65 francs.

Opportunités: afin d’obtenir un rendement proportionnel à deux chiffres avec l’Early Redemption Kick-In GOAL (symbole : KCSEDU) sur AMS, il faudra toutefois que l’action n’enregistre aucune avancée. Si la marge de sécurité de 40% est suffisante, le rendement maximal de 10.00% p.a. sera échu en tout juste un an. Le nouveau Double Coupon Kick-In GOAL (symbole : KCRRDU) sur AMS, Infineon et Intel offre une belle chance de gain de 20%. Si à l’échéance le trio s’établit au moins au niveau de sortie ou davantage, le coupon classique de 10% p.a. est doublé. La barrière est éloignée des cours de départ par une marge confortable de 40%.

Risques: les Kick-In GOALS ne bénéficient d’aucune protection du capital. Si, pendant la durée de l’investissement, l’un des sous-jacents atteint une seule fois la barrière respective («Kick-In Level») ou est inférieur à celle-ci, et que la fonction de remboursement anticipé ne s’applique pas, le remboursement par amortissement à l’échéance est basé sur la performance la plus faible (base Strike) du panier (au maximum toutefois à la valeur nominale majorée du coupon). Dans un tel cas, des pertes sont probables. De plus, avec les produits structurés, l’investisseur supporte le risque d’émetteur. Cela signifie qu’en cas d’insolvabilité d’UBS SA, le capital investi peut être perdu, indépendamment de l’évolution des sous-jacents.

Vous trouverez davantage de produits UBS et des informations sur les opportunités et les risques à l’adresse ubs.com/keyinvest.

AMS vs. Infineon vs. Intel (5 ans, aux fins d’illustration uniquement, données en %)¹

ams infineon

Au total, on constate de nettes augmentations sur 5 ans pour les trois actions du secteur des puces et semi-conducteurs. AMS a obtenu les meilleurs résultats. Toutefois, ce fournisseur d’Apple a enregistré récemment de nettes pertes.

Source: UBS AG, Bloomberg

Valeurs du: 19.10.2018

AMS (5 ans)¹

ams

Le fabricant autrichien de semi-conducteurs AMS a débuté il y a environ deux ans un fort mouvement haussier. Lorsque les cours ont dépassé 100 francs, une correction est intervenue.

Source: UBS AG, Bloomberg

Valeurs du: 19.10.2018

¹) La performance passée n’indique pas les résultats futures.
²) Les condition des ETTs sont vérifiés annuellement et peuvent être ajustées avec un délai de 13 mois après la publication.

10.00% p.a. Double Coupon Worst of Kick-In GOAL sur AMS, Infineon, Intel

Symbol KCRRDU
SVSP Name Barrier Reverse Convertible
SPVSP Code 1230, Variable Coupon
Sous-jacent AMS, Infineon, Intel
Devise CHF (Quanto)
Coupon 10.00% p.a.
Double Coupon Trigger Level 100%
Kick-In Level 60%
Echéance 31.10.2019
Émetteur UBS AG, London
Date de fixation du prix 31.10.2018, 15:00 h
 

10.00% p.a. ER Kick-In GOAL sur AMS

Symbol KCSEDU
SVSP Name Barrier Reverse Convertible
SPVSP Code 1230, Auto-Callable
Sous-jacent AMS
Devise CHF
Coupon 10.00% p.a.
Strike Level 100%
Kick-In Level 60%
Echéance 02.11.2020
Émetteur UBS AG, London
Date de fixation du prix 31.10.2018, 15:00 h
 

Vous trouverez davantage de produits UBS et des informations sur les opportunités et les risques à l’adresse ubs.com/keyinvest.

Source: UBS AG, Bloomberg

Valeurs du: 19.10.2018

Apérçu du marché

Index Citation Semaine¹
SMI™ 8’750.35 -1.6%
SLI™ 1’399.69 -1.2%
S&P 500™ 2’809.21 0.8%
Euro STOXX 50™ 3’243.08 -0.7%
S&P™ BRIC 40 3’868.91 1.0%
CMCI™ Compos. 965.12 0.1%
Gold (once troy) 1’227.40 2.8%

¹ Changement basé sur le cours de clôture du jour précédent par rapport au cours de clôture de la semaine dernière.

SMI™ vs. VSMI™ 1 année

L’index VSMI™ est calculé depuis 2005. Il affiche la volatilité des actions inclus dans le SMI™ index. Pour la calculation, un portefeuille est utilisé qui ne réagit qu’au variations de la volatilité au lieu des variations des prix. En le faisant, la méthodologie du VSMI™ utilise la volatilité carré, connu sous le terme variance, des options sur le SMI avec 30 jours jusqu’à l’échéance négociées à la Bourse Eurex.

Source: UBS AG, Bloomberg

Valeurs du: 19.10.2018

BMW/Tesla
Un constructeur Premium au courant

Le secteur automobile bruisse de partout. Outre les risques internationaux générés par le conflit douanier ou le Brexit, les régulateurs exercent leur pression sur les constructeurs en mettant en place de nouvelles procédures en matière de tests antipollution. Même si les affaires quotidiennes en souffrent, les groupes ne perdent pas de vue leurs chances futures. Récemment, BMW a créé l’événement. Le constructeur allemand a été le premier étranger à acquérir la majorité dans une joint-venture chinoise. Aux Etats-Unis, c’est Tesla qui fait les grands titres avec des chiffres de production en hausse. De juillet à septembre, 53 239 véhicule du modèle 3 très porteur sont sortis des chaînes, c’est-à-dire plus du double qu’au deuxième trimestre. UBS réunit désormais ces deux constructeurs Premium dans un Callable Worst of Kick-In GOAL (symbole : KCRQDU). Les conditions sont stimulantes : la barrière est établie à 50% du cours initial, le coupon correspond à 20.00% p.a. ce qui est supérieur à la moyenne.

Le charismatique chef de Tesla, pionnier de la voiture électrique, aime les surprises. Actuellement, Elon Musc essaie de transformer l’ordinateur de bord de la Tesla en une console de jeu vidéo. Si cette lubie est loin d’être réalité, les investisseurs eux attendent avec impatience les chiffres du troisième trimestre. Après un premier semestre plutôt faible, Musc a laissé entrevoir qu’il allait désormais travailler de manière « durablement profitable ». Le 30 octobre, Tesla publiera son rapport intermédiaire. Les chiffres positifs ne posent pas de problème pour BMW, mais les Munichois ont récemment effrayé les investisseurs avec un avertissement sur les bénéfices. Toutefois, le groupe automobile ne pratique pas la politique de l’autruche et s’efforce d’avancer. BMW renforce de 25 à 75% sa participation à la joint-venture avec son partenaire chinois Brilliance, et paie à cet effet 3.6 milliards d’euros. Normalement, à partir de 2022, BMW devrait pouvoir consolider totalement Brilliance Automotive dans son bilan. « C’est une nouvelle ère qui commence pour nous », explique Harald Krüger, le PDG du groupe. (Source : Thomson Reuters, revue de presse, 11.10.2018)

Opportunités: BMW et Tesla n’auront pas à accélérer pour amener le Callable Worst of Kick-In GOAL (symbole : KCRQDU) à destination, avec profit. Au contraire : les deux actions automobiles disposent d’une marge de 50% à la baisse sans que l’opportunité de gain de 20% p.a. soit bloquée. La durée maximale d’un an peut être réduite de six mois au maximum en raison de la fonction Callable.

Risques: il n’existe aucune protection du capital pour le produit présenté. Si, pendant la durée de l’investissement, l’un des sous-jacents atteint une seule fois la barrière respective («Kick-In Level») ou est inférieur à celle-ci, et que la fonction de Callable ne s’applique pas, le remboursement à l’échéance par remboursement en espèces est basé sur la performance la plus faible (base Strike) du duo (au maximum toutefois à la valeur nominale majorée du coupon). Dans un tel cas, des pertes sont probables. Par ailleurs, avec les produits structurés, l’investisseur supporte le risque d’émetteur. Cela signifie qu’en cas d’insolvabilité d’UBS SA, le capital investi peut être perdu, indépendamment de l’évolution du sous-jacent.

Vous trouverez davantage de produits UBS et des informations sur les opportunités et les risques à l’adresse ubs.com/keyinvest.

BMW vs. Tesla
(5 ans, aux fins d’illustration uniquement, données en %)¹

bmw

Source: UBS AG, Bloomberg

Valeurs du: 19.10.2018

20.00% p.a. Callable Worst of Kick-In GOAL sur BMW et Tesla

Symbol KCRQDU
SVSP Name Barrier Reverse Convertible
SPVSP Code 1230, Callable
Sous-jacent BMW, Tesla
Devise EUR (Quanto)
Coupon 20.00% p.a.
Kick-In Level 50.00%
Echéance 24.10.2019
Émetteur UBS AG, London
Date de fixation du prix 24.10.2018
 

Vous trouverez davantage de produits UBS et des informations sur les opportunités et les risques à l’adresse ubs.com/keyinvest.

Source: UBS AG, Bloomberg

Valeurs du: 19.10.2018

¹) La performance passée n’indique pas les résultats futures.
²) Les condition des ETTs sont vérifiés annuellement et peuvent être ajustées avec un délai de 13 mois après la publication.

This material has been prepared by UBS AG or one of its affiliates («UBS»). This material is for distribution only as permitted by law. It is not prepared for the needs of any specific recipient. It is published solely for information and is not a solicitation or offer to buy or sell any securities or related financial instruments (“Instruments”). UBS makes no representation or warranty, either express or implied, on the completeness or reliability of the information contained in this document (“Information”) except that concerning UBS AG and its affiliates. The Information should not be regarded by recipients as a substitute for using their own judgment. Any opinions expressed in this material may change without notice and may be contrary to opinions expressed by other business areas of UBS as a result of using different assumptions or criteria. UBS is under no obligation to update the Information. UBS, its officers, employees or clients may have or have had an interest in the Instruments and may at any time transact in them. UBS may have or have had a relationship with entities referred to in the Information. Neither UBS nor any of its affiliates, or their officers or employees, accepts any liability for any loss arising from use of the Information. This presentation is not a basis for entering into a transaction. Any transaction between you and UBS will be subject to the detailed provisions of the term sheet, confirmation or electronic matching systems relating to that transaction. Clients wishing to effect transactions should contact their local sales representative.
This information is communicated by UBS AG and/or its affiliates («UBS»). * (see below) UBS may from time to time, as principal or agent, have positions in, or may buy or sell, or make a market in any securities, currencies, financial instruments or other assets underlying the product to which this website relates (the «Structured Product»). UBS may provide investment banking and other services to and/or have officers who serve as directors of the companies referred to in this website. UBS’s trading and/or hedging activities related to the Structured Product may have an impact on the price of the underlying asset and may affect the likelihood that any relevant barrier or relevant trigger event is crossed or triggered. UBS has policies and procedures designed to minimise the risk that officers and employees are influenced by any conflicting interest or duty and that confidential information is improperly disclosed or made available. UBS may pay or receive brokerage or retrocession fees in connection with the Structured Product described herein. In respect of any Structured Product that is a security, UBS may, in certain circumstances, sell the Structured Product to dealers and other financial institutions at a discount to the issue price or rebate to them for their own account some proportion of the issue price. Further information is available on request. Structured Products are complex and may involve a high risk of loss. Prior to purchasing the Structured Product you should consult with your own legal, regulatory, tax, financial and accounting advisors to the extent you consider it necessary, and make your own investment, hedging and trading decisions (including decisions regarding the suitability of the Structured Product) based upon your own judgement and advice from those advisers you consider necessary. Save as otherwise expressly agreed in writing, UBS is not acting as your financial adviser or fiduciary in relation to the Product. UBS generally hedges its exposure to Structured Products, although it may elect not to hedge or to partially hedge any Structured Product. UBS’s hedging activity may be conducted through transactions in the underlying asset, index or instrument or in options, futures or other derivatives related to the underlying asset, index or instrument on publicly traded markets or otherwise, and may have an impact on the price of the under-lying asset. If a transaction is cash settled, UBS will generally unwind or offset any hedge it has for such Structured Product in close proximity to the relevant valuation time or period. In some cases, this activity may affect the value of the Structured Product. Unless stated otherwise in this document, (i) this document is for information purposes only and should not be construed as an offer, personal recommendation or solicitation to purchase the Structured Product and should not be treated as giving investment advice, and (ii) the terms of any investment in the Structured Product will be exclusively subject to the detailed provisions, including risk considerations, contained in the more detailed legal documentation that relates to the Structured Product (being the confirmation, information memorandum, prospectus or other issuer documentation as relevant). UBS makes no representation or warranty relating to any information herein which is derived from independent sources. This document shall not be copied or reproduced without UBS’s prior written permission. In respect of any Structured Product that is a security, no action has been or will be taken in any jurisdiction that would permit a public offering of the Product, save where explicitly stated in the issuer documentation. The Structured Product must be sold in accordance with all applicable selling restrictions in the jurisdictions in which it is sold.
© UBS 2018. All rights reserved. UBS prohibits the forwarding of this information without the approval of UBS.
Weekly-Hits édition de 19.10.20182018-10-19T09:13:32+02:00

Weekly-Hits edition of 19.10.2018

KeyInvest Weekly Hits

Friday, 19.10.2018

  • Topic 1: Microchip equities - Opportunity to get involved in this sector thanks to the sell-off
  • Topic 2: BMW & Tesla - Premium manufacturers revved up

Microchip equities
Opportunity to get involved in this sector thanks to the sell-off

There was recently a wave of sales in the microchip sector. The Philadelphia Semiconductor Index fell by more than 4% within a single week. Infineon was hit even harder, with the DAX equity declining by around twice as much in the same period. AMS has also been on the “to sell” list of stock exchange speculators for some time now, and the microchip specialist has lost more than a quarter of its market capitalization in the space of a month.¹ Following the general sell-off in the sector, it might now make sense to consider entering the market at this low base. In view of the uncertain situation on the stock markets, however, conditional partial protection is a must. The Double Coupon Kick-In GOAL (symbol: KCRRDU) in subscription on AMS, Infineon and Intel has attractive conditions. In addition to a risk buffer of 40% and a coupon of 10% p.a., the product also offers the additional opportunity of being able to double the return. For those who prefer a product with only one underlying, should take a look at the Early Redemption Kick-In GOAL (symbol: KCSEDU) on AMS, with which a coupon of 10% p.a. is possible within just two years.

Although semiconductor companies are currently exposed to severe fluctuations on the stock market, the industry continues to grow. According to the experts at IC Insights, the global microchip market is expected to grow by 14% to USD 509.1 billion this year, exceeding the half trillion US dollar mark for the very first time. In light of new technology trends such as Big Data, the Internet of Things (IoT) and artificial intelligence, the demand for microchips could continue to remain high. IC Insights estimates that the percentage of electronic products being fitted with semiconductors will increase from 28.8% in 2017 to 31.5% in 2022. (Source: IC Insights, July 18, 2018)

According to analysts at CIO WM, the healthy demand for semiconductors is already being reflected in the activities of the majority of the industry’s big players. Therefore, the experts currently classify the sector as “neutral”, highlighting Intel as their preferred company. The microchip giant is also heavily involved in future trends such as data centers and IoT. In the second quarter, the two segments grew by an estimable 27% and 22%, respectively. Intel expects record sales for the current financial year, thus making it the third year in a row in which they have done so.
At Infineon, too, the signs continue to point to growth. In the wake of the recent share price fluctuation, the Germans confirmed their growth targets for 2018/19 (September 30). “We see no reason to question the outlook,” said an Infineon spokesperson (Source: Thomson Reuters media release, October 10, 2019). The Group expects sales to grow by 10%. Austria-based AMS, which is primarily known as an Apple supplier, is also growing strongly, but faces margin pressure. Even though UBS IB Research sees opportunities for AMS in 3D-sensor technology, the experts rate the equity as “Neutral” and have lowered the target price to CHF 65.

Opportunities: In order to achieve a double-digit percentage return with the Early Redemption Kick-In GOAL (symbol: KCSEDU) on AMS, the equity does not need to grow. If the risk buffer of 40% is maintained, the maximum return of 10% p.a. will be paid out in just under a year. The new Double Coupon Kick-In GOAL (symbol: KCRRDU) on AMS, Infineon and Intel offers a lofty 20% return opportunity. If the three equities are at least level with or above the initial price upon maturity, the traditional coupon of 10% p.a. will be doubled. The barrier stands at a comfortable 40% of the initial fixing price.

Risks: Kick-In GOALs do not have capital protection. If the underlyings touch or fall below the respective Kick-In Level (barrier) and the early redemption feature does not apply, the amount repaid on the maturity date is reflecting the worst performance of the underlyings (but not more than notional value plus coupon). In this case, it is likely that losses will be incurred. Investors in structured products are also exposed to issuer risk, which means that the capital invested may be lost if UBS AG becomes insolvent, regardless of the performance of the underlying.

More UBS products and further information on the risks and opportunities are available at ubs.com/keyinvest.

AMS vs. Infineon vs. Intel (5 years; for illustrative purposes only; figures in %)¹

ams infineon

The three microchip equities are ultimately showing clear upward growth over the next 5 years, with AMS faring the best. Nevertheless, the Apple supplier recently suffered significant losses.

Source: UBS AG, Bloomberg

As of 19.10.2018

AMS (5 years)¹

ams

Austrian semiconductor manufacturer AMS has enjoyed a steep upward trend, which started some two years ago. A correction phase subsequently set in when prices rose above 100 francs.

Source: UBS AG, Bloomberg

As of: 19.10.2018

¹) Please be aware that past performance does not indicate future results.
²) The conditions of ETTs are reviewed on a yearly basis and can be adjusted with a deadline of 13 months after the announcement.

10.00% p.a. Double Coupon Worst of Kick-In GOAL on AMS, Infineon, Intel

Symbol KCRRDU
SVSP Name Barrier Reverse Convertible
SPVSP Code 1230, Variable Coupon
Underlying AMS, Infineon, Intel
Currency CHF (Quanto)
Coupon 10.00% p.a.
Double Coupon Trigger Level 100%
Kick-In Level 60%
Expiry 31.10.2019
Issuer UBS AG, London
Subscription until 31.10.2018, 15:00 h
 

10.00% p.a. ER Kick-In GOAL on AMS

Symbol KCSEDU
SVSP Name Barrier Reverse Convertible
SPVSP Code 1230, Auto-Callable
Underlying AMS
Currency CHF
Coupon 10.00% p.a.
Strike-Level 100%
Kick-In Level 60%
Expiry 02.11.2020
Issuer UBS AG, London
Subscription until 31.10.2018, 15:00 h
 

More UBS products and further information on the risks and opportunities are available at ubs.com/keyinvest.

Source: UBS AG, Bloomberg

As of: 19.10.2018

Market overview

Index Quotation Week¹
SMI™ 8’750.35 -1.6%
SLI™ 1’399.69 -1.2%
S&P 500™ 2’809.21 0.8%
Euro STOXX 50™ 3’243.08 -0.7%
S&P™ BRIC 40 3’868.91 1.0%
CMCI™ Compos. 965.12 0.1%
Gold (troy ounce) 1’227.40 2.8%

¹ Change based on the closing price of the previous day compared to the closing price a week ago.

SMI™ vs. VSMI™ 1 year

smi vs vsmi

The VSMI™ Index is calculated since 2005. It shows the volatility of the stocks within the SMI™ index. A portfolio which reacts only to changes in volatility instead of volatility itself is relevant for the calculation. Thereby, the VSMI™ methodology uses the squared volatility, known as variance, of the SMI options with remaining time to expiry of 30 days traded at the Eurex.

Source: UBS AG, Bloomberg

As of: 19.10.2018

BMW & Tesla
Premium manufacturers revved up

The automotive industry is currently being hit from all sides. In addition to international risks as a result of the customs conflict and Brexit, regulators are also exerting pressure on manufacturers with new exhaust emission tests. Although day-to-day business is consequently suffering, the companies are not losing sight of their future opportunities. BMW made a massive statement of intent recently. The German firm was the first foreign car company to succeed in acquiring a majority stake in a Chinese joint venture. In contrast, Tesla is making headlines in the US thanks to its rising production figures. From July to September, 53,239 bodies of the Model 3 cars on which the company has pinned its hopes rolled off the production line – more than twice as many as in the second quarter. UBS is now packaging the two premium manufacturers into a Callable Worst of Kick-In GOAL (symbol: KCRQDU), offering amazing conditions. The barrier stands at 50% of the initial price and the coupon totals 20% p.a.

The charismatic boss of the electric car pioneer Tesla is always good for a surprise. Elon Musk is currently trying to retrofit the on-board computer in the Tesla to include a video game console. Although this is still a long way off from bearing fruit, investors are eagerly awaiting the figures for the third quarter. After a weak first half-year, Musk had promised “sustainably profitable” work from now on. Tesla will publish its interim report on October 30. Although remaining in the black is no problem for competitor BMW, the Munich-based company did scare off investors with a profit warning. Nevertheless, the car company has decided not to stick its head in the sand, but continue to put the pedal to the metal instead. For example, BMW is increasing its stake in the joint venture with its Chinese partner Brilliance by 25% to 75%, paying EUR 3.6 billion in return. We expect to be able to fully consolidate BMW Brilliance Automotive in the balance sheet from 2022 onwards,” said BMW CEO Harald Krüger. (Source: Thomson Reuters media report, October 11, 2018)

Opportunities: BMW and Tesla don’t have to switch to the fast lane for the new Callable Worst of Kick-In GOAL (symbol: KCRQDU) to be profitable. On the contrary: The two automotive equities have a downward margin of 50% before the brakes are put on the potential maximum return of 20% p.a. The maximum term of one year can be shortened by a maximum of half a year due to the callable function.

Risks: This product does not have capital protection. If the underlyings touch or fall below the respective Kick-In Level (barrier) and the callable feature does not apply, the amount repaid on the maturity date is reflecting the worst performance of the underlyings (but not more than notional value plus coupon). In this case, it is likely that losses will be incurred. Investors in structured products are also exposed to issuer risk, which means that the capital invested may be lost if UBS AG becomes insolvent, regardless of the performance of the underlying.

More UBS products and further information on the risks and opportunities are available at ubs.com/keyinvest.

BMW vs. Tesla
(5 years; for illustrative purposes only; figures in %)¹

bmw

Source: UBS AG, Bloomberg

As of: 19.10.2018

20.00% p.a. Callable Worst of Kick-In GOAL on BMW and Tesla

Symbol KCRQDU
SVSP Name Barrier Reverse Convertible
SPVSP Code 1230, Callable
Underlyings BMW, Tesla
Currency EUR (Quanto)
Coupon 20.00% p.a.
Kick-In Level 50.00%
Expiry 24.10.2019
Issuer UBS AG, London
Subscription until 24.10.2018
 

More UBS products and further information on the risks and opportunities are available at ubs.com/keyinvest.

Source: UBS AG, Bloomberg

As of: 19.10.2018

¹) Please be aware that past performance does not indicate future results.
²) The conditions of ETTs are reviewed on a yearly basis and can be adjusted with a deadline of 13 months after the announcement.

This material has been prepared by UBS AG or one of its affiliates («UBS»). This material is for distribution only as permitted by law. It is not prepared for the needs of any specific recipient. It is published solely for information and is not a solicitation or offer to buy or sell any securities or related financial instruments (“Instruments”). UBS makes no representation or warranty, either express or implied, on the completeness or reliability of the information contained in this document (“Information”) except that concerning UBS AG and its affiliates. The Information should not be regarded by recipients as a substitute for using their own judgment. Any opinions expressed in this material may change without notice and may be contrary to opinions expressed by other business areas of UBS as a result of using different assumptions or criteria. UBS is under no obligation to update the Information. UBS, its officers, employees or clients may have or have had an interest in the Instruments and may at any time transact in them. UBS may have or have had a relationship with entities referred to in the Information. Neither UBS nor any of its affiliates, or their officers or employees, accepts any liability for any loss arising from use of the Information. This presentation is not a basis for entering into a transaction. Any transaction between you and UBS will be subject to the detailed provisions of the term sheet, confirmation or electronic matching systems relating to that transaction. Clients wishing to effect transactions should contact their local sales representative.
This information is communicated by UBS AG and/or its affiliates («UBS»). * (see below) UBS may from time to time, as principal or agent, have positions in, or may buy or sell, or make a market in any securities, currencies, financial instruments or other assets underlying the product to which this website relates (the «Structured Product»). UBS may provide investment banking and other services to and/or have officers who serve as directors of the companies referred to in this website. UBS’s trading and/or hedging activities related to the Structured Product may have an impact on the price of the underlying asset and may affect the likelihood that any relevant barrier or relevant trigger event is crossed or triggered. UBS has policies and procedures designed to minimise the risk that officers and employees are influenced by any conflicting interest or duty and that confidential information is improperly disclosed or made available. UBS may pay or receive brokerage or retrocession fees in connection with the Structured Product described herein. In respect of any Structured Product that is a security, UBS may, in certain circumstances, sell the Structured Product to dealers and other financial institutions at a discount to the issue price or rebate to them for their own account some proportion of the issue price. Further information is available on request. Structured Products are complex and may involve a high risk of loss. Prior to purchasing the Structured Product you should consult with your own legal, regulatory, tax, financial and accounting advisors to the extent you consider it necessary, and make your own investment, hedging and trading decisions (including decisions regarding the suitability of the Structured Product) based upon your own judgement and advice from those advisers you consider necessary. Save as otherwise expressly agreed in writing, UBS is not acting as your financial adviser or fiduciary in relation to the Product. UBS generally hedges its exposure to Structured Products, although it may elect not to hedge or to partially hedge any Structured Product. UBS’s hedging activity may be conducted through transactions in the underlying asset, index or instrument or in options, futures or other derivatives related to the underlying asset, index or instrument on publicly traded markets or otherwise, and may have an impact on the price of the under-lying asset. If a transaction is cash settled, UBS will generally unwind or offset any hedge it has for such Structured Product in close proximity to the relevant valuation time or period. In some cases, this activity may affect the value of the Structured Product. Unless stated otherwise in this document, (i) this document is for information purposes only and should not be construed as an offer, personal recommendation or solicitation to purchase the Structured Product and should not be treated as giving investment advice, and (ii) the terms of any investment in the Structured Product will be exclusively subject to the detailed provisions, including risk considerations, contained in the more detailed legal documentation that relates to the Structured Product (being the confirmation, information memorandum, prospectus or other issuer documentation as relevant). UBS makes no representation or warranty relating to any information herein which is derived from independent sources. This document shall not be copied or reproduced without UBS’s prior written permission. In respect of any Structured Product that is a security, no action has been or will be taken in any jurisdiction that would permit a public offering of the Product, save where explicitly stated in the issuer documentation. The Structured Product must be sold in accordance with all applicable selling restrictions in the jurisdictions in which it is sold.
© UBS 2018. All rights reserved. UBS prohibits the forwarding of this information without the approval of UBS.
Weekly-Hits edition of 19.10.20182018-10-19T09:14:50+02:00

Gold: Verschmähtes Edelmetall mit Comeback-Chancen

KeyInvest Blog

Montag, 08. Oktober 2018

Gold: Verschmähtes Edelmetall mit Comeback-Chancen

Die globalen Auseinandersetzungen nehmen zu und dennoch lassen Anleger die Krisenwährung links liegen. Ein Hauptbelastungsfaktor der Goldschwäche ist der starke US-Dollar. Doch könnte die Stimmung schon bald drehen und dem Edelmetall wieder glanzvolle Zeiten bescheren.

Die Welt ist in Aufruhr: Die politischen und wirtschaftlichen Entwicklungen zeigen, dass die internationalen Kapitalmärkte mit steigenden Risikofaktoren konfrontiert werden. Auf der einen Seite herrschen Krisen in Schwellenländern wie der Türkei und Argentinien, die einen Flächenbrand in den Emerging Markets auslösen könnten. Auf der anderen Seite stehen die Handelskonflikte zwischen den USA und Europa, China sowie Japan. Dazu kommt noch das zehnjährige Jubiläum der Lehman-Krise am 15. September, welche Anleger wieder schmerzlich daran erinnert, dass Aktienkurse auch fallen können.

Spielball der Währungen

Angesichts dieser Gemengelage wäre es nicht verwunderlich, wenn Gold eine wahre Renaissance erleben würde. Doch das Gegenteil ist der Fall: Die Krisenwährung notiert seit Jahresbeginn mit einem Minus von 8.5 Prozent (Stand: 05.09.2018) deutlich im negativen Bereich. Im April setzte die Abwärtsbewegung bei Kursen oberhalb der 1’300er-Marke ein, Mitte August tauchte das Edelmetall dann sogar erstmals seit 15 Monaten unter 1’200 US-Dollar. Ein entscheidender Richtungsgeber für den Goldpreis ist die Währungsentwicklung. Der US-Dollar-Index, der die Stärke des Greenbacks gegenüber seinen sechs wichtigsten Rivalen darstellt, markierte zuletzt den höchsten Stand seit Mitte 2017.* Angesichts der Stärke des US-Dollar haben die Experten von UBS CIO GWM ihre Dreimonats-Handelsspanne für Gold im August auf 1,125 – 1,240 US-Dollar pro Unze reduziert. Das Aufwärtspotenzial wurde zudem auf Sicht von sechs und zwölf Monaten auf 1’250 respektive 1’300 US-Dollar pro Unze gesenkt (Quelle: CIO GWM Research, «Gold: Asien ist zurück», 21.09.2018).

Neben den Währungen drückten zuletzt auch vermehrt spekulative Verkäufe auf den Goldkurs. Zudem mussten die Investoren ihre US-Dollar-Engagements weniger absichern, da sich die US-Aktienmärkte auf Rekordhöhen bewegen. «Die niedrige Marktvolatilität des US-Marktes hat renditestarke US-Dollar-Anlagen besonders attraktiv gemacht, was die Goldabflüsse von ETFs und Spekulanten-Konten bestätigen», konstatieren die Analysten von UBS CIO GWM Research. (Quelle: CIO GWM Research, «Gold: Zeit zum umdenken», 17.08.2018)

Goldene Zeiten

Wie lange die Währungsrallye noch anhalten wird, ist fraglich. Zwar spricht der Zinsvorsprung für den US-Dollar, doch könnte nur eine geringe Abweichung der US-Notenbank Fed von ihrem geldpolitischen Kurs die Devise ausbremsen. Dass dies nicht komplett abwegig ist, machte Donald Trump jüngst klar. Der amerikanische Präsident attackierte den von ihm ernannten Fed-Chef Jerome Powell. Er sieht nämlich durch eine weitere Straffung der Leitsätze die Wirtschaftsentwicklung gefährdet. Er sei «nicht begeistert» über dessen Zinserhöhungen, kritisierte Trump in einem Interview mit der Nachrichtenagentur Reuters Mitte August.

Für einen Abgesang auf Gold könnte es also zu früh sein. Eventuell steht sogar ein Comeback an. Nach einer technisch überverkauften Lage sind starke Gegenbewegungen keine Seltenheit. Im Bereich von 1’125 US-Dollar pro Unze befindet sich zudem eine Unterstützungsmarke, die auf Ende 2016 zurückgeht. Darüber hinaus ist Gold weiterhin ein adäquates Instrument für die Portfoliodiversifizierung. Und sollten sich die eingangs skizzierten Krisen rund um den Erdball weiter verschärfen, könnten wieder mehr Anleger den «sicheren Hafen» ansteuern.

Grund zum Optimismus

Grundsätzlich erachtet es Haefele jedoch als wichtig, investiert zu bleiben. Er hält es für durchaus möglich, dass sich jüngsten Zollandrohungen als Verhandlungstaktik erweisen. Wäre diese der Fall, blieben die Aussichten freundlich. In der Vergangenheit war es dem CIO zufolge eher falsch, zu vorsichtig als zu optimistisch zu agieren. Marc Haefele begründet diese These mit der historischen Entwicklung des S&PTM 500: In der Nachkriegszeit hat der US-Leitindex in Zeiträumen von sechs Monaten 2.3 Mal häufiger positive als negative Renditen erzielt. Bei einem Betrachtungszeitraum von fünf Jahren lag die entsprechende Quote sogar bei 5.8. (Quelle: UBS House View Monthly Letter, 19.07.2018)

Alles in allem käme es für Investoren nun zunächst darauf an, kein übermässiges Risiko einzugehen und sich auf das kurzfristige Abwärtspotenzial vorzubereiten. Haefele sieht verschiedene Möglichkeiten, mit denen sich Anleger für Portfoliowachstum positionieren, aber auch die kurzfristigen Risiken begrenzen können: Dazu zählt er beispielsweise die Beimischung von alternativen Anlagen wie Hedge Funds oder die Diversifikation über Länder und Sektoren. Als weiteres Instrument nennt der Kapitalmarktprofi die Anlage in Vermögenswerten, die von langfristigen Trends profitieren. Vor allem Aktien aus den Bereichen E-Commerce und Software haben zuletzt eine Outperformance erwirtschaft. Dahinter verbergen sich häufig Geschäftsmodelle, die von strukturellen Entwicklungen wie Bevölkerungswachstum und -alterung sowie Urbanisierung profitieren. Haefele hält solche Unternehmen für besser positioniert, um den Wachstums- und Handelssorgen standzuhalten, als stärker vom Konjunkturzyklus abhängige Gesellschaften. (Quelle: UBS House View Monthly Letter, 19.07.2018)

Entwicklung des Goldpreises in den letzten 5 Jahren (in USD)

keyinvest blog chart

Quelle: Bloomberg, UBS. Zeitraum: 09.10.2013 bis 08.10.2018.*

* Bitte beachten Sie, dass vergangene Wertentwicklungen keine Indikationen für künftige Wertentwicklungen sind.

Weitere Blogeinträge:

Eine prall gefüllte Agenda

Am Mittwochabend hat das Warten ein Ende: Um 20:00 Uhr unserer Zeit wird die US-Notenbank ihre gelpolitische Beschlusslage veröffentlichen.

Top-Performer unter Druck

Inflation, Zinsen, Omikron – diese drei Schlagwörter bestimmen an der Börse das Geschehen. Nach einem starken Auftakt in das Jahr scheint das unliebsame Trio den Investoren die Kauflaune erst einmal verdorben zu haben.

Zick-Zack-Kurs zum Jahresauftakt

Das neue Börsenjahr hat so begonnen, wie das alte aufgehört hat: mit Rekordmarken. Gleich am 3. Januar 2022, dem ersten Handelstag, erreichte der SMI® ein Allzeithoch von 12'997.15 Punkten.

Showdown vor Heiligabend

„Die Notenbanker haben das Wort“, so lautete der Titel in der vergangenen Woche an dieser Stelle.

Gold: Verschmähtes Edelmetall mit Comeback-Chancen2018-10-25T07:51:22+02:00

Weekly-Hits édition de 12.10.2018

KeyInvest Weekly Hits

Vendredi, 12.10.2018

  • Thème 1: Criminalité sur Internet - En toute sécurité sur l’autoroute des données
  • Thème 2: Technique médicale - Un secteur en plein essor

Criminalité sur Internet
En toute sécurité sur l’autoroute des données

Les attaques de pirates informatiques font actuellement la une des journaux. Par exemple, la Grande-Bretagne accuse la Russie d’être responsable de cyberattaques contre des institutions politiques. (Source : Thomson Reuters, article de presse, 04.10.2018). En plus, un scandale lié à des données volées sur Facebook fait sensation : selon le groupe américain, les pirates ont utilisé une brèche de sécurité pour espionner quelque 50 millions de profils. (Source : https://newsroom.fb.com/news/2018/09/security-update/). Ces exemples montrent bien qu’il faut toujours améliorer et renforcer les mécanismes de protection. En conséquence, la demande de prestations de sécurité informatique devrait rester forte à l’avenir, qu’elle provienne des utilisateurs privés, des entreprises ou même des Etats. Cette tendance de long terme pourrait aussi convenir pour des placements de capitaux. L’Open End PERLES sur l’indice Solactive Global Cyber Security permet d’investir simplement et à bon compte dans ce secteur. Les produits négociés en francs suisses (symbole : KCFJDU) et dollar US (symbole : KCFKDU) sont soumis à une commission de gestion de 0.75% p.a.

L’exemple de Siemens montre de manière impressionnante l’importance de la cybersécurité. 1275 collaborateurs sont responsables de la sécurité informatique du groupe industriel. Et ils ne chôment pas, puisque Siemens enregistre quelque 1000 attaques par jour. On comprend très vite que la sécurité informatique est un marché global portant sur des milliards. Selon le rapport « Cybersecurity Market by Solution », les dépenses mondiales dans ce domaine atteindront pour l’année en cours un volume de 152.71 milliards de dollars US. Et la tendance est à la hausse. En 2023, on estime que le marché s’établira à 248.26 milliards de dollars US, ce qui correspond à un taux de croissance annuelle moyen de 10.2% entre 2018 et 2023. Outre les attaques de pirates informatiques toujours plus fréquentes, le durcissement des directives relatives à la protection des données constitue le moteur principal de cette évolution. (Source : MarketsandMarktes, septembre 2018). La sécurité sur Internet est un vaste domaine. Le cryptage, les antivirus, les pare-feu ou la récupération des données ne sont que quelques secteurs parmi d’autres auxquels les entreprises de sécurité informatique doivent s’intéresser. Il pourrait donc être judicieux d’investir de manière diversifiée dans cette tendance de croissance. L’indice Solactive Global Cyber Security contient au total 14 entreprises de sécurité internationales qui sont toutes des spécialistes dans leurs domaines. Si, par exemple, le Japonais Trend Micro est surtout connu pour ses logiciels antivirus, la société israélienne Check Point Software se distingue par ses produits pare-feu et VPN. Fortinet est actuellement un poids lourd de l’indice. L’entreprise a même créé une filiale indépendante spécialisée dans les produits de cybersécurité pour les autorités gouvernementales l’année dernière a été récemment adoubée par le fournisseur d’indices S&P Dow Jones. A partir du 11 octobre 2018, Fortinet remplacera l’action d’Envision Healthcare Corp. Dans le S&P 500™. Une forte progression du cours a précédé cette « promotion ». La valeur en bourse de Fortinet a même progressé de 113% en un an.¹

Opportunités: la courbe de cours de l’indice Solactive Global Cyber Security est également en forte hausse. Si le baromètre a dû payer son tribut à la récente faiblesse du marché, l’indice a atteint mi-septembre un nouveau record. Depuis Nouvel an, la hausse se résume à 21.4%.¹ L’Open End PERLES en francs suisses (symbole : KCFJDU) et en dollars US (symbole : KCFKDU) permet aux investisseurs d’accéder facilement aux entreprises proposant des solutions de sécurité informatique prometteuses. Les produits participent à l’identique l’évolution de l’indice Solactive Global Cyber Security NTR. Une commission de gestion de 0.75% est due, et les dividendes nets versés aux membres sont réinvestis.

Risques: il n’existe aucune protection du capital pour les produits présentés. Une évolution négative de la valeur de base génère des pertes correspondantes pour l’Open End PERLES. Il faut également prendre en compte le risque de change, car la monnaie dans laquelle les produits sont négociés peut être différente de celle des membres de l’indice. Par ailleurs, avec les produits structurés, l’investisseur supporte le risque d’émetteur. Cela signifie qu’en cas d’insolvabilité d’UBS SA, le capital investi peut être perdu, indépendamment de l’évolution du sous-jacent.

Vous trouverez davantage de produits UBS et des informations sur les opportunités et les risques à l’adresse ubs.com/keyinvest.

Indice Solactive Global Cyber Security USD NTR depuis le 18.10.2013 (jour du lancement)¹

solactive

Le secteur de la sécurité informatique bénéficie de la hausse des dépenses de sécurité. Ceci apparaît nettement dans l’indice Solactive Global Cyber Security qui a réalisé un rendement moyen de 19.9% depuis sa création.

Source: UBS AG, Bloomberg

Valeurs du: 10.10.2018

Check Point Software vs. Fortinet vs. F5 Networks (5 ans)¹
(Aux fins d’illustration uniquement, données en %)

Check Point Software, Fortinet et F5 Networks, les poids lourds actuels de l’indice Solactive Global Cyber Security, affichent de nettes progressions sur cinq ans. Fortinet a même été multiplié par plus de quatre.

Source: UBS AG, Bloomberg

Valeurs du: 10.10.2018

¹) La performance passée n’indique pas les résultats futures.
²) Les condition des ETTs sont vérifiés annuellement et peuvent être ajustées avec un délai de 13 mois après la publication.

Open End PERLES sur Solactive Global Cyber Security NTR Index (CHF)

Symbol KCFJDU
SVSP Name Tracker certificat
SPVSP Code 1300
Sous-jacent Solactive Global Cyber Security USD NTR Index
Rapport de souscription 1:1
Devise CHF
Frais de gestion 0.75% p.a.
Participation 100%
Echéance Open End
Émetteur UBS AG, London
Bid/Ask CHF 200.10 / 202.20
 

Open End PERLES sur Solactive Global Cyber Security NTR Index (USD)

Symbol KCFKDU
SVSP Name Tracker certificat
SPVSP Code 1300
Sous-jacent Solactive Global Cyber Security USD NTR Index
Rapport de souscription 1:1
Devise USD
Frais de gestion 0.75% p.a.
Participation 100%
Echéance Open End
Émetteur UBS AG, London
Bid/Ask USD 202.00 /204.00
 

Vous trouverez davantage de produits UBS et des informations sur les opportunités et les risques à l’adresse ubs.com/keyinvest.

Source: UBS AG, Bloomberg

Valeurs du: 10.10.2018

Apérçu du marché

Index Citation Semaine¹
SMI™ 8’892.88 -3.1%
SLI™ 1’416.66 -4.8%
S&P 500™ 2’785.68 -4.8%
Euro STOXX 50™ 3’266.90 -4.1%
S&P™ BRIC 40 3’829.43 -4.9%
CMCI™ Compos. 963.86 -1.4%
Gold (once troy) 1’193.40 -1.4%

¹ Changement basé sur le cours de clôture du jour précédent par rapport au cours de clôture de la semaine dernière.

SMI™ vs. VSMI™ 1 année

L’index VSMI™ est calculé depuis 2005. Il affiche la volatilité des actions inclus dans le SMI™ index. Pour la calculation, un portefeuille est utilisé qui ne réagit qu’au variations de la volatilité au lieu des variations des prix. En le faisant, la méthodologie du VSMI™ utilise la volatilité carré, connu sous le terme variance, des options sur le SMI avec 30 jours jusqu’à l’échéance négociées à la Bourse Eurex.

Source: UBS AG, Bloomberg

Valeurs du: 10.10.2018

Technique médicale

Un secteur en plein essor

Agitation sur le marché des aides auditives : la société américaine Bose connue pour ses haut-parleurs s’est vu accorder l’autorisation pour un appareil auditif par la FDA (autorité sanitaire américaine). Les personnes souffrant de pertes auditives légères à moyennes peuvent l’adapter à leurs besoins. Le renforcement de la concurrence a mis la pression sur les actions de la société suisse Sonova. Après l’annonce, les titres ont perdu environ dix pour cent de leur valeur. Il en est allé de même pour la société de technique médicale Straumann¹ en raison notamment d’annonces de résultats faibles dans le secteur. Stratec Biomedical a ainsi surpris avec un avertissement sur les bénéfices. A vu du niveau de cours désormais modéré de Sonova et Straumann, un produit avec protection partielle sur ce duo pourrait être intéressant. Dans ce contexte, l’Early Redemption (ER) Worst of Kick-In GOAL en souscription (symbole : KCQVDU) offre des conditions attrayantes : Si la barrière de 69% des cours initiaux reste intacte, le produit générera dans un an le montant maximum de 12 % par an.

Deux facteurs doivent être pris en compte si l’on considère la faiblesse actuelle du cours de Sonova : tout d’abord, le groupe a lancé le 10 octobre son vaste programme de rachat d’actions. Le fabricant d’aides auditives envisage d’y consacrer jusqu’à 1.5 milliard de francs. De plus, le 16 octobre sera un jour important pour les investisseurs. Les acteurs du marché espèrent que, lors de la réunion, Sonova annoncera un nouvel appareil auditif qui fera de l’ombre aux produits de la concurrence. Pour Straumann, la fin octobre sera passionnante. C’est là que le spécialiste des implants présentera ses résultats du troisième trimestre. Les résultats semestriels avaient surpris positivement : la direction a renforcé ses prévisions de croissance organique en 2018 à environ 15%.

Opportunités: des avancées de cours pour les deux actions de technique médicale présentées ne sont pas nécessaires pour que le nouveau ER Worst of Kick-In GOAL (symbole : KCQVDU) produise le rendement maximal de 5%. Il faut seulement qu’aucun titre n’atteigne ou ne passe en-dessous de la barrière de 69% du niveau initial pendant la période de 18 mois. Avec la fonction « Early Redemption », le montant maximal peut toutefois être atteint plus tôt. Il faut pour cela que Sonova et Straumann atteignent ou dépassent ensemble le cours initial à l’un des jours d’observation trimestriel (première observation : 24.10.2019).

Risques: il n’existe aucune protection du capital pour le produit présenté. Si, pendant la durée de l’investissement, l’un des sous-jacents atteint une seule fois la barrière respective («Kick-In Level») ou est inférieur à celle-ci, et que la fonction de remboursement anticipé ne s’applique pas, le remboursement par amortissement en espèces à l’échéance est basé sur la performance la plus faible (base Strike) du duo (au maximum toutefois à la valeur nominale majorée du coupon). Dans un tel cas, des pertes sont probables. Par ailleurs, avec les produits structurés, l’investisseur supporte le risque d’émetteur. Cela signifie qu’en cas d’insolvabilité d’UBS SA, le capital investi peut être perdu, indépendamment de l’évolution des sous-jacents.

Vous trouverez davantage de produits UBS et des informations sur les opportunités et les risques à l’adresse ubs.com/keyinvest.

Sonova vs. Straumann (5 ans)¹
(Aux fins d’illustration uniquement, données en %)

Source: UBS AG, Bloomberg

Valeurs du: 10.10.2018

5.00% p.a. ER Worst of Kick-In GOAL sur Sonova / Straumann

Symbol KCQVDU
SVSP Name Barrier Reverse Convertible
SPVSP Code 1230 (Auto-Callable)
Sous-jacent Sonova, Straumann
Devise CHF
Coupon 5.00% p.a.
Kick-In Level 69.00%
Echéance 23.04.2020
Émetteur UBS AG, London
Date de fixation du prix 24.10.2018, 15:00 h
 

Vous trouverez davantage de produits UBS et des informations sur les opportunités et les risques à l’adresse ubs.com/keyinvest.

Source: UBS AG, Bloomberg

Valeurs du: 10.10.2018

¹) La performance passée n’indique pas les résultats futures.
²) Les condition des ETTs sont vérifiés annuellement et peuvent être ajustées avec un délai de 13 mois après la publication.

This material has been prepared by UBS AG or one of its affiliates («UBS»). This material is for distribution only as permitted by law. It is not prepared for the needs of any specific recipient. It is published solely for information and is not a solicitation or offer to buy or sell any securities or related financial instruments (“Instruments”). UBS makes no representation or warranty, either express or implied, on the completeness or reliability of the information contained in this document (“Information”) except that concerning UBS AG and its affiliates. The Information should not be regarded by recipients as a substitute for using their own judgment. Any opinions expressed in this material may change without notice and may be contrary to opinions expressed by other business areas of UBS as a result of using different assumptions or criteria. UBS is under no obligation to update the Information. UBS, its officers, employees or clients may have or have had an interest in the Instruments and may at any time transact in them. UBS may have or have had a relationship with entities referred to in the Information. Neither UBS nor any of its affiliates, or their officers or employees, accepts any liability for any loss arising from use of the Information. This presentation is not a basis for entering into a transaction. Any transaction between you and UBS will be subject to the detailed provisions of the term sheet, confirmation or electronic matching systems relating to that transaction. Clients wishing to effect transactions should contact their local sales representative.
This information is communicated by UBS AG and/or its affiliates («UBS»). * (see below) UBS may from time to time, as principal or agent, have positions in, or may buy or sell, or make a market in any securities, currencies, financial instruments or other assets underlying the product to which this website relates (the «Structured Product»). UBS may provide investment banking and other services to and/or have officers who serve as directors of the companies referred to in this website. UBS’s trading and/or hedging activities related to the Structured Product may have an impact on the price of the underlying asset and may affect the likelihood that any relevant barrier or relevant trigger event is crossed or triggered. UBS has policies and procedures designed to minimise the risk that officers and employees are influenced by any conflicting interest or duty and that confidential information is improperly disclosed or made available. UBS may pay or receive brokerage or retrocession fees in connection with the Structured Product described herein. In respect of any Structured Product that is a security, UBS may, in certain circumstances, sell the Structured Product to dealers and other financial institutions at a discount to the issue price or rebate to them for their own account some proportion of the issue price. Further information is available on request. Structured Products are complex and may involve a high risk of loss. Prior to purchasing the Structured Product you should consult with your own legal, regulatory, tax, financial and accounting advisors to the extent you consider it necessary, and make your own investment, hedging and trading decisions (including decisions regarding the suitability of the Structured Product) based upon your own judgement and advice from those advisers you consider necessary. Save as otherwise expressly agreed in writing, UBS is not acting as your financial adviser or fiduciary in relation to the Product. UBS generally hedges its exposure to Structured Products, although it may elect not to hedge or to partially hedge any Structured Product. UBS’s hedging activity may be conducted through transactions in the underlying asset, index or instrument or in options, futures or other derivatives related to the underlying asset, index or instrument on publicly traded markets or otherwise, and may have an impact on the price of the under-lying asset. If a transaction is cash settled, UBS will generally unwind or offset any hedge it has for such Structured Product in close proximity to the relevant valuation time or period. In some cases, this activity may affect the value of the Structured Product. Unless stated otherwise in this document, (i) this document is for information purposes only and should not be construed as an offer, personal recommendation or solicitation to purchase the Structured Product and should not be treated as giving investment advice, and (ii) the terms of any investment in the Structured Product will be exclusively subject to the detailed provisions, including risk considerations, contained in the more detailed legal documentation that relates to the Structured Product (being the confirmation, information memorandum, prospectus or other issuer documentation as relevant). UBS makes no representation or warranty relating to any information herein which is derived from independent sources. This document shall not be copied or reproduced without UBS’s prior written permission. In respect of any Structured Product that is a security, no action has been or will be taken in any jurisdiction that would permit a public offering of the Product, save where explicitly stated in the issuer documentation. The Structured Product must be sold in accordance with all applicable selling restrictions in the jurisdictions in which it is sold.
© UBS 2018. All rights reserved. UBS prohibits the forwarding of this information without the approval of UBS.
Weekly-Hits édition de 12.10.20182018-10-12T07:59:45+02:00

Weekly-Hits edition of 12.10.2018

KeyInvest Weekly Hits

Friday, 12.10.2018

  • Topic 1: Cybercrime - Security on the information superhighway
  • Topic 2: Medical technology - A sector in upheaval

Cybercrime
Security on the information superhighway

Hacker attacks are currently a hot topic in the media. For example, the UK is accusing Russia of being responsible for cyber attacks made against political institutions. (Source: Thomson Reuters media report, October 10, 2018) A data scandal on Facebook is also causing quite a stir. According to the US company, hackers exploited a breach in security, which enabled them to spy on approximately 50 million profiles (Source: https://newsroom.fb.com/news/2018/09/security-update/). These examples show that the protection mechanisms used need to be improved and become more effective. Consequently, the demand for IT security services – from private users and companies to entire countries – is likely to remain high in the future. This long-term trend could also be a good capital investment. The Open End PERLES on the Solactive Global Cyber Security Index make it easy and cost-effective to invest in the sector. The products, which can be traded in Swiss francs (symbol: KCFJDU) and US dollars (symbol: KCFKDU), have a management fee of 0.75% p.a.

Siemens is an impressive example of the significance of cybersecurity. A total of 1,275 employees are responsible for IT security at the industrial group. After all, Siemens records around 1,000 attacks a day. It is rapidly becoming clear that IT security is a global market worth billions. According to the «Cybersecurity Market by Solution» report, global spending in this area will reach a volume of USD 152.71 billion in the current year – and this figure is set to increase in the future. Estimates state that the market will grow to USD 248.26 billion by 2023, corresponding to an average annual growth rate of 10.2% between 2018 and 2023. The main drivers behind this are the increasing number of hacker attacks and stricter data protection guidelines. (Source: MarketsandMarktes, September 2018) Internet security is a wide-ranging field. Encryption, anti-virus protection, firewalls and data recovery are just a few of the areas that IT security companies need to address. It could therefore make sense to diversify your portfolio by investing in this growth trend. The Solactive Global Cyber Security Index includes a total of 14 international security companies, all of which are specialists in their fields. For example, Japanese company Trend Micro is best known for its antivirus software, while Israeli firm Check Point Software excels in firewall and VPN products. The current heavyweight in the index is Fortinet. The company, which last year even founded an independent subsidiary that focuses solely on cybersecurity products for government agencies, recently received a fillip from the index provider S&P Dow Jones. As of October 11, 2018, Fortinet replaced Envision Healthcare Corp. on the S&P 500™ indices. The “promotion” came as a result of a strong share price performance, as the market value of Fortinet increased by a huge 113% within the space of a year.¹

Opportunities: The price curve of the Solactive Global Cyber Security Index is likewise trending strongly upward. Although the barometer also paid the price for the recent market weakness, the index reached a new record high until mid-September. Positive growth of 21.4% has been recorded since the end of the year 2017.¹ The Open End PERLES in Swiss francs (symbol: KCFJDU) and US dollars (symbol: KCFKDU) give investors easy access to companies offering promising IT security solutions. The products track the performance of the Solactive Global Cyber Security NTR Index. Although there is an annual management fee of 0.75%, the net dividends distributed to members are reinvested.

Risks: The aforementioned products do not have capital protection. Should the underlying assets deliver a negative performance; the Open End PERLES will incur commensurate losses. The currency risk must also be taken into account, as the trading currency of the products may differ from the currencies of the index members. Investors in structured products are also exposed to issuer risk, which means that the capital invested may be lost if UBS AG becomes insolvent, regardless of the performance of the underlying.

More UBS products and further information on the risks and opportunities are available at ubs.com/keyinvest.

Solactive Global Cyber Security USD NTR Index since October 18, 2013 (launch day)¹

solactive

The IT security sector benefits from the increase in spending on security. This is impressively reflected in the Solactive Global Cyber Security Index, which has achieved an average return of 19.9% p.a. since its launch.

Source: UBS AG, Bloomberg

As of 10.10.2018

Check Point Software vs. Fortinet vs. F5 Networks (5 years) ¹
(for illustrative purposes only; figures in %)

The current heavyweights on the Solactive Global Cyber Security Index – Check Point Software, Fortinet and F5 Networks – are posting significant growth on a five-year basis. Fortinet has even recorded growth in excess of 400%.

Source: UBS AG, Bloomberg

As of: 10.10.2018

¹) Please be aware that past performance does not indicate future results.
²) The conditions of ETTs are reviewed on a yearly basis and can be adjusted with a deadline of 13 months after the announcement.

Open End PERLES on Solactive Global Cyber Security NTR Index (CHF)

Symbol KCFJDU
SVSP Name Tracker-Certificate
SPVSP Code 1300
Underlying Solactive Global Cyber Security USD NTR Index
Ratio 1:1
Currency CHF
Administration fee 0.75% p.a.
Participation 100%
Expiry Open End
Issuer UBS AG, London
Bid/Ask CHF 200.10 / 202.20
 

Open End PERLES on Solactive Global Cyber Security NTR Index (USD)

Symbol KCFKDU
SVSP Name Tracker-Certificate
SPVSP Code 1300
Underlying Solactive Global Cyber Security USD NTR Index
Ratio 1:1
Currency USD
Administration fee 0.75% p.a.
Participation 100%
Expiry Open End
Issuer UBS AG, London
Bid/Ask USD 202.00 /204.00
 

More UBS products and further information on the risks and opportunities are available at ubs.com/keyinvest.

Source: UBS AG, Bloomberg

As of: 10.10.2018

Market overview

Index Quotation Week¹
SMI™ 8’892.88 -3.1%
SLI™ 1’416.66 -4.8%
S&P 500™ 2’785.68 -4.8%
Euro STOXX 50™ 3’266.90 -4.1%
S&P™ BRIC 40 3’829.43 -4.9%
CMCI™ Compos. 963.86 -1.4%
Gold (troy ounce) 1’193.40 -1.4%

¹ Change based on the closing price of the previous day compared to the closing price a week ago.

SMI™ vs. VSMI™ 1 year

smi vs vsmi

The VSMI™ Index is calculated since 2005. It shows the volatility of the stocks within the SMI™ index. A portfolio which reacts only to changes in volatility instead of volatility itself is relevant for the calculation. Thereby, the VSMI™ methodology uses the squared volatility, known as variance, of the SMI options with remaining time to expiry of 30 days traded at the Eurex.

Source: UBS AG, Bloomberg

As of: 10.10.2018

Medical technology
A sector in upheaval

Commotion on the hearing aid market: The US company Bose, known for its speaker systems, has received FDA approval for a hearing aid. People with mild to moderate hearing loss can adjust the settings of this device to meet their needs. The increase in the competition on the market has placed the shares of Sonova under pressure, with the Swiss company’s equities losing about a tenth of their value following the announcement. Medical technology company Straumann also experienced a similar situation.¹ Weak tidings from the industry, among other things, has had a negative impact here. For example, Stratec Biomedical provided a huge surprise by issuing a profit warning. In view of the now reduced share prices of Sonova and Straumann, a partial protection product on the duo might make sense. The Early Redemption (ER) Worst of Kick-In GOAL (symbol: KCQVDU) in subscription offers attractive conditions in this regard. If the barrier remains intact at 69% of the starting prices, the product will yield a maximum amount of 5% p.a. in 18 months at the latest.

Two factors should not be overlooked in the current weakness of Sonova’s share price: Firstly, the group started its extensive share buy-back program on October 10. The hearing aid manufacturer would like to spend up to 1.5 billion Swiss francs on this program. Secondly, an important investors’ day will be held on October 16. Market participants hope that Sonova will use the meeting to announce a new hearing aid that will outperform competing products. At Straumann, on the other hand, things will only start getting exciting at the end of October, as this is when the implant specialist will publish its results for the third quarter. The company’s half-year figures delivered a positive surprise, as management increased its forecast for organic growth in 2018 by some 15%.

Opportunities: The two aforementioned medical technology equities do not need to post price gains for the new ER Worst of Kick-In GOAL (symbol: KCQVDU) to yield the maximum return of 5% p.a. All that is required is that both equites remain above the barrier of 69% of the initial fixing levels during the 18-month term. However, due to the early redemption function, the maximum return can also be achieved earlier. For this to happen, Sonova and Straumann both have to be at or above the initial fixed price on one of the quarterly observation days (first date: October 24, 2019).

Risks: This product does not have capital protection. If the underlyings touch or fall below the respective Kick-In Level (barrier) and the early redemption feature does not apply, the amount repaid on the maturity date is reflecting the worst performance of the underlyings (but not more than notional value plus coupon). In this case, it is likely that losses will be incurred. Investors in structured products are also exposed to issuer risk, which means that the capital invested may be lost if UBS AG becomes insolvent, regardless of the performance of the underlying.

More UBS products and further information on the risks and opportunities are available at ubs.com/keyinvest.

Sonova vs. Straumann (5 years) ¹
(for illustrative purposes only; figures in %)

Source: UBS AG, Bloomberg

As of: 10.10.2018

5.00% p.a. ER Worst of Kick-In GOAL on Sonova / Straumann

Symbol KCQVDU
SVSP Name Barrier Reverse Convertible
SPVSP Code 1230 (Auto-Callable)
Underlyings Sonova, Straumann
Currency CHF
Coupon 5.00% p.a.
Kick-In Level 69.00%
Expiry 23.04.2020
Issuer UBS AG, London
Subscription until 24.10.2018, 15:00 h
 

More UBS products and further information on the risks and opportunities are available at ubs.com/keyinvest.

Source: UBS AG, Bloomberg

As of: 10.10.2018

¹) Please be aware that past performance does not indicate future results.
²) The conditions of ETTs are reviewed on a yearly basis and can be adjusted with a deadline of 13 months after the announcement.

This material has been prepared by UBS AG or one of its affiliates («UBS»). This material is for distribution only as permitted by law. It is not prepared for the needs of any specific recipient. It is published solely for information and is not a solicitation or offer to buy or sell any securities or related financial instruments (“Instruments”). UBS makes no representation or warranty, either express or implied, on the completeness or reliability of the information contained in this document (“Information”) except that concerning UBS AG and its affiliates. The Information should not be regarded by recipients as a substitute for using their own judgment. Any opinions expressed in this material may change without notice and may be contrary to opinions expressed by other business areas of UBS as a result of using different assumptions or criteria. UBS is under no obligation to update the Information. UBS, its officers, employees or clients may have or have had an interest in the Instruments and may at any time transact in them. UBS may have or have had a relationship with entities referred to in the Information. Neither UBS nor any of its affiliates, or their officers or employees, accepts any liability for any loss arising from use of the Information. This presentation is not a basis for entering into a transaction. Any transaction between you and UBS will be subject to the detailed provisions of the term sheet, confirmation or electronic matching systems relating to that transaction. Clients wishing to effect transactions should contact their local sales representative.
This information is communicated by UBS AG and/or its affiliates («UBS»). * (see below) UBS may from time to time, as principal or agent, have positions in, or may buy or sell, or make a market in any securities, currencies, financial instruments or other assets underlying the product to which this website relates (the «Structured Product»). UBS may provide investment banking and other services to and/or have officers who serve as directors of the companies referred to in this website. UBS’s trading and/or hedging activities related to the Structured Product may have an impact on the price of the underlying asset and may affect the likelihood that any relevant barrier or relevant trigger event is crossed or triggered. UBS has policies and procedures designed to minimise the risk that officers and employees are influenced by any conflicting interest or duty and that confidential information is improperly disclosed or made available. UBS may pay or receive brokerage or retrocession fees in connection with the Structured Product described herein. In respect of any Structured Product that is a security, UBS may, in certain circumstances, sell the Structured Product to dealers and other financial institutions at a discount to the issue price or rebate to them for their own account some proportion of the issue price. Further information is available on request. Structured Products are complex and may involve a high risk of loss. Prior to purchasing the Structured Product you should consult with your own legal, regulatory, tax, financial and accounting advisors to the extent you consider it necessary, and make your own investment, hedging and trading decisions (including decisions regarding the suitability of the Structured Product) based upon your own judgement and advice from those advisers you consider necessary. Save as otherwise expressly agreed in writing, UBS is not acting as your financial adviser or fiduciary in relation to the Product. UBS generally hedges its exposure to Structured Products, although it may elect not to hedge or to partially hedge any Structured Product. UBS’s hedging activity may be conducted through transactions in the underlying asset, index or instrument or in options, futures or other derivatives related to the underlying asset, index or instrument on publicly traded markets or otherwise, and may have an impact on the price of the under-lying asset. If a transaction is cash settled, UBS will generally unwind or offset any hedge it has for such Structured Product in close proximity to the relevant valuation time or period. In some cases, this activity may affect the value of the Structured Product. Unless stated otherwise in this document, (i) this document is for information purposes only and should not be construed as an offer, personal recommendation or solicitation to purchase the Structured Product and should not be treated as giving investment advice, and (ii) the terms of any investment in the Structured Product will be exclusively subject to the detailed provisions, including risk considerations, contained in the more detailed legal documentation that relates to the Structured Product (being the confirmation, information memorandum, prospectus or other issuer documentation as relevant). UBS makes no representation or warranty relating to any information herein which is derived from independent sources. This document shall not be copied or reproduced without UBS’s prior written permission. In respect of any Structured Product that is a security, no action has been or will be taken in any jurisdiction that would permit a public offering of the Product, save where explicitly stated in the issuer documentation. The Structured Product must be sold in accordance with all applicable selling restrictions in the jurisdictions in which it is sold.
© UBS 2018. All rights reserved. UBS prohibits the forwarding of this information without the approval of UBS.
Weekly-Hits edition of 12.10.20182018-10-19T07:37:58+02:00

Weekly-Hits édition de 08.10.2018

KeyInvest Weekly Hits

Lundi, 08.10.2018

Keyinvest Weekly Hits
  • Thème 1: Réforme fiscale américaine – Les entreprises américaines prennent leur essor
  • Thème 2: Airbus / Boeing – Des carnets de commande pleins à craquer

Réforme fiscale américaine
Les entreprises américaines prennent leur essor

L’économie américaine est en pleine effervescence : au premier trimestre 2018, le produit intérieur brut (PIB) a progressé aux Etats-Unis, pour atteindre une valeur annuelle estimée de 4.2%. Parallèlement, sur le marché du travail, c’est de fait le plein emploi. La réforme fiscale mise en œuvre en début d’année sert de moteur essentiel à ce boom. Afin d’offrir aux investisseurs une possibilité de participer pleinement aux bénéfices des entreprises potentiellement avantagées, UBS a lancé en décembre 2017 le US Tax Reform Beneficiaries Basket. Jusqu’à présent, le calcul de ce choix se révèle exact : la valeur du PERLES (symbole : USTAXU) sur le panier a progressé de 11.3% depuis le début de l’année, c’est-à-dire qu’elle a fait mieux que l’indice S&P 500™.

Cette réforme fiscale de grande envergure était l’une des principales promesses de campagne de Donald Trump. En 2016, dans la course à la Maison blanche, le républicain avait fait miroiter d’importants allègements pour les particuliers et les entreprises, conformément à sa devise « America First ! ». Juste avant Noël 2017, environ onze mois après sa prise de pouvoir, Trump a signé le paquet de lois très contesté à Washington, mettant ainsi en œuvre la plus grande réforme fiscale depuis 30 ans aux Etats-Unis. Désormais, il apparaît que cette mesure dont l’un des éléments centraux est une nette réduction de l’impôt sur les sociétés est efficace. La réforme ne relance pas que l’économie américaine en tant que tout. Selon UBS CIO WM, elle se remarque aussi positivement dans les résultats des entreprises. Les experts désignent les allègements fiscaux comme la « cerise sur le gâteau » dans un environnement déjà positif. Concrètement, elle pourrait accélérer la croissance des résultats de cette année aux Etats-Unis de 8%. Au total, UBS CIO WM prévoit pour l’année en cours une hausse de 18% des profits. (Source : UBS CIO WM, « UBS House view Monthly Base », octobre 2018, 20.09.2018). Il est établi que le marché américain des actions en général, et les bénéficiaires de la réforme fiscale en particulier, font actuellement l’objet d’une forte demande de la part des investisseurs. Si d’autres places boursières importantes ont à peine évolué au cours des trois premiers trimestres de 2018, le S&P 500™ a enchaîné les records. Fin septembre 2018, l’indice de référence comptabilisait une hausse de tout juste 9%. Pendant ce temps, le US Tax Reform Beneficiaries Basket a augmenté de plus de 11%.

Juste avant que la réforme ait été décidée, UBS avait proposé cette possibilité en décembre dernier. L’impulsion avait été donnée par UBS Research. Les analystes de l’entreprise pensaient à l’époque que la réforme fiscale américaine n’était que partiellement intégrée dans les cours des actions. En conséquence, ils ont commencé à rechercher systématiquement de possibles bénéficiaires. Un critère central pour la composition du panier a été l’effet de la réforme sur les liquidités, et son rapport avec la capitalisation de marché. Afin d’éviter un trop grand écart par rapport à la composition de l’indice S&P 500™, les experts ont limité le nombre d’actions par secteur. Il en est résulté une légère surpondération des entreprises particulièrement bénéficiaires de la réforme.

A ce jour par exemple, la part relativement importante des entreprises healthcare et technologiques dans le US Tax Reform Beneficiaries Basket s’avère efficace. Pour le second secteur cité, la réforme fiscale facilite en outre un climat de consommation américain favorable. Il en est de même pour le commerce de détail. Dans ce secteur, ce sont notamment Kohl’s et Macy’s qui ont été pris en considération – à ce jour, les actions des deux grands magasins américains ont progressé en 2018 d’environ 37%.

Opportunités: le Tracker Certificat (symbole : USTAXU) sur le US Tax Reform Beneficiaries Basket n’est pas encore au bout de la première année de ses sept ans d’échéance. Les investisseurs peuvent en conséquence encore miser sur l’effet à long terme de la réforme fiscale américaine. La commission de gestion pour ce produit de participation est de 0.30% p.a. D’éventuels dividendes versés par les membres du panier sont réinvestis net dans l’action à l’origine du versement.

Risques: il n’existe aucune protection du capital pour le produit présenté. Il peut y avoir des pertes avec le PERLES lorsque le panier sous-jacent baisse. Par ailleurs, avec les produits structurés, l’investisseur supporte le risque d’émetteur. Cela signifie qu’en cas d’insolvabilité d’UBS SA, le capital investi peut être perdu, indépendamment de l’évolution du sous-jacent.

Vous trouverez davantage de produits UBS et des informations sur les opportunités et les risques à l’adresse ubs.com/keyinvest.

HCA Healthcare vs. Centene vs. Humana (5 ans)¹
(Aux fins d’illustration uniquement, données en %)

Les trois entreprises du secteur de la santé CA Healthcare, Centene et Humana comptent parmi les plus performantes du US Tax Reform Beneficiaries Basket. En 2018, le trio a encore accéléré sa tendance haussière.

Source: UBS AG, Bloomberg

Valeurs du: 03.10.2018

Kohl’s vs. Macy’s vs. Gap (5 ans)¹

(Aux fins d’illustration uniquement, données en %)

Les cours des actions des deux commerces de détail Kohl’s et Macy’s ont commencé à grimper après la mise en place de la réforme fiscale. En revanche, des problèmes opérationnels freinent la chaîne de magasins de mode Gap.

Source: UBS AG, Bloomberg

Valeurs du: 03.10.2018

¹) La performance passée n’indique pas les résultats futures.
²) Les condition des ETTs sont vérifiés annuellement et peuvent être ajustées avec un délai de 13 mois après la publication.

PERLES sur US Tax Reform Beneficiaries Basket

Symbol USTAXU
SVSP Name Tracker-certificat
SPVSP Code 1300
Sous-jacent US Tax Reform Beneficiaries Basket
Rapport de souscription 1:1
Devise USD
Frais de gestion 0.30% p.a.
Participation 100%
Echéance 20.10.2024
Émetteur UBS AG, London
Bid/Ask USD 1’135.00 / 1’145.00
 

US Tax Reform Beneficiaries Basket: Pondération initiale par secteur (Valeurs du: 04.12.2017)

Technologie 18%
Finances 16%
Soins de santé 16%
Non-Staples à la consommation 14%
Industrie 12%
Staples à la consommation 10%
Autre 14%
 

Vous trouverez davantage de produits UBS et des informations sur les opportunités et les risques à l’adresse ubs.com/keyinvest.

Source: UBS AG, Bloomberg

Valeurs du: 03.10.2018

Apérçu du marché

Index Citation Semaine¹
SMI™ 9’175.21 Pkt. 1.0%
SLI™ 1’488.05 Pkt. 0.0%
S&P 500™ 2’925.51 Pkt. 0.7%
Euro STOXX 50™ 3’405.48 Pkt. -0.8%
S&P™ BRIC 40 4’028.54 Pkt. -0.7%
CMCI™ Compos. 977.18 Pkt. 3.6%
Gold (once troy) 1’202.90 USD 0.3%

¹ Changement basé sur le cours de clôture du jour précédent par rapport au cours de clôture de la semaine dernière.

SMI™ vs. VSMI™ 1 année

L’index VSMI™ est calculé depuis 2005. Il affiche la volatilité des actions inclus dans le SMI™ index. Pour la calculation, un portefeuille est utilisé qui ne réagit qu’au variations de la volatilité au lieu des variations des prix. En le faisant, la méthodologie du VSMI™ utilise la volatilité carré, connu sous le terme variance, des options sur le SMI avec 30 jours jusqu’à l’échéance négociées à la Bourse Eurex.

Source: UBS AG, Bloomberg

Valeurs du: 03.10.2018

Airbus / Boeing
Des carnets de commande pleins à craquer

Dans le duel qui oppose les constructeurs d’avions Airbus et Boeing, le leader américain du secteur a pour l’instant une longueur d’avance. De janvier à août 2018, Boeing a enregistré des commandes nettes pour 581 appareils. Pendant la même période, Airbus a dû se contenter de commandes nettes pour 219 appareils. La récente évolution de cours des deux rivaux est similaire: alors que l’action Airbus marque le pas, Boeing débute le quatrième trimestre avec un nouveau record absolu.¹ UBS réunit maintenant les deux géants de la branche dans un Early Redemption (ER) Worst of Kick-In GOAL (symbole: KCOADU). Les investisseurs peuvent prévoir ici un versement de coupon d’un montant de 7,50% p.a. Actuellement, les sous-jacents entrent dans la période de deux ans avec une marge de sécurité de 40%.

En dépit du creux récent en matière de commandes, le carnet de commandes d’Airbus reste bien rempli. A la fin-août 2018, le groupe comptabilisait, selon ses propres indications, des commandes pour un total de 7415 appareils. Aux taux de production actuels, la production serait ainsi pleinement occupée pour environ neuf ans. Finalement, Airbus a obtenu une commande de la plus grande compagnie aérienne d’Europe. Lufthansa a converti des options d’achat pour 27 appareils de type A320 neo et A321 neo en commandes fermes. Dix des avions très peu gourmands en carburant de cette commande devraient être exploités pour SWISS. (Source : Airbus, Communiqué de presse, 01.10.2018) Chez Boeing, le légendaire 737 est un succès absolu. De janvier à août 2018, presque trois commandes sur quatre concernaient les modèles traditionnels. Le 737 MAX en particulier fait l’objet d’une forte demande. Boeing indique qu’au cours des plus de 100 ans d’histoire de l’entreprise, aucun avion ne s’est aussi bien vendu que ce modèle ultramoderne. Selon l’entreprise, quelque 4700 commandes de plus de 100 clients ont été passées pour le 737 MAX. (Source : Boeing.com) Les investisseurs découvriront le 24 octobre la situation du leader de la branche en ce qui concerne les bénéfices, lors de la publication par Boeing des résultats pour le 3e trimestre. Six jours après, Airbus donnera un aperçu de la marche récente de ses affaires.

Opportunités: juste avant les échéances de résultats, UBS émet le ER Worst of Kick-In GOAL (symbole: KCOADU) sur Airbus et Boeing. Le duo permet un coupon de 7,50% p.a. Les barrières sont situées à 60% du niveau initial des deux actions. Tant qu’aucun sous-jacent n’atteint ce niveau, ou n’y est inférieur, le produit s’inscrit avec un rendement maximal correspondant au coupon. S’ajoute à cela une possibilité de remboursement anticipé avec coupon proportionnel. La fonction de remboursement anticipé s’applique si Airbus et Boeing atteignent ensemble le cours initial lors d’une des journées d’observation trimestrielles ou sont supérieurs à celui-ci, pour la première fois au 19 octobre 2019.

Risques: il n’existe aucune protection du capital pour le produit présenté. Si, pendant la durée de l’investissement, l’un des sous-jacents atteint une seule fois la barrière respective («Kick-In Level») ou est inférieur à celle-ci, et que la fonction de remboursement anticipé ne s’applique pas, le remboursement par amortissement en espèces à l’échéance est basé sur la performance la plus faible (base Strike) du duo (au maximum toutefois à la valeur nominale majorée du coupon). Dans un tel cas, des pertes sont probables. Par ailleurs, avec les produits structurés, l’investisseur supporte le risque d’émetteur. Cela signifie qu’en cas d’insolvabilité d’UBS SA, le capital investi peut être perdu, indépendamment de l’évolution du sous-jacent.

Vous trouverez davantage de produits UBS et des informations sur les opportunités et les risques à l’adresse ubs.com/keyinvest.

Airbus vs. Boeing (5 ans)¹
(Aux fins d’illustration uniquement, données en %)

Source: UBS AG, Bloomberg

Valeurs du: 03.10.2018

7.50% p.a. Early Redemption Worst of Kick-In GOAL sur Airbus / Boeing

Symbol KCOADU
SVSP Name Barrier Reverse Convertible
SPVSP Code 1230 (Auto-Callable)
Sous-jacent Airbus / Boeing
Devise EUR
Coupon 7.50% p.a.
Kick-In Level 60.00%
Echéance 12.10.2020
Émetteur UBS AG, London
Date de fixation du prix 10.10.2018, 15:00 h
 

Vous trouverez davantage de produits UBS et des informations sur les opportunités et les risques à l’adresse ubs.com/keyinvest.

Source: UBS AG, Bloomberg

Valeurs du: 03.10.2018

¹) La performance passée n’indique pas les résultats futures.
²) Les condition des ETTs sont vérifiés annuellement et peuvent être ajustées avec un délai de 13 mois après la publication.

This material has been prepared by UBS AG or one of its affiliates («UBS»). This material is for distribution only as permitted by law. It is not prepared for the needs of any specific recipient. It is published solely for information and is not a solicitation or offer to buy or sell any securities or related financial instruments (“Instruments”). UBS makes no representation or warranty, either express or implied, on the completeness or reliability of the information contained in this document (“Information”) except that concerning UBS AG and its affiliates. The Information should not be regarded by recipients as a substitute for using their own judgment. Any opinions expressed in this material may change without notice and may be contrary to opinions expressed by other business areas of UBS as a result of using different assumptions or criteria. UBS is under no obligation to update the Information. UBS, its officers, employees or clients may have or have had an interest in the Instruments and may at any time transact in them. UBS may have or have had a relationship with entities referred to in the Information. Neither UBS nor any of its affiliates, or their officers or employees, accepts any liability for any loss arising from use of the Information. This presentation is not a basis for entering into a transaction. Any transaction between you and UBS will be subject to the detailed provisions of the term sheet, confirmation or electronic matching systems relating to that transaction. Clients wishing to effect transactions should contact their local sales representative.
This information is communicated by UBS AG and/or its affiliates («UBS»). * (see below) UBS may from time to time, as principal or agent, have positions in, or may buy or sell, or make a market in any securities, currencies, financial instruments or other assets underlying the product to which this website relates (the «Structured Product»). UBS may provide investment banking and other services to and/or have officers who serve as directors of the companies referred to in this website. UBS’s trading and/or hedging activities related to the Structured Product may have an impact on the price of the underlying asset and may affect the likelihood that any relevant barrier or relevant trigger event is crossed or triggered. UBS has policies and procedures designed to minimise the risk that officers and employees are influenced by any conflicting interest or duty and that confidential information is improperly disclosed or made available. UBS may pay or receive brokerage or retrocession fees in connection with the Structured Product described herein. In respect of any Structured Product that is a security, UBS may, in certain circumstances, sell the Structured Product to dealers and other financial institutions at a discount to the issue price or rebate to them for their own account some proportion of the issue price. Further information is available on request. Structured Products are complex and may involve a high risk of loss. Prior to purchasing the Structured Product you should consult with your own legal, regulatory, tax, financial and accounting advisors to the extent you consider it necessary, and make your own investment, hedging and trading decisions (including decisions regarding the suitability of the Structured Product) based upon your own judgement and advice from those advisers you consider necessary. Save as otherwise expressly agreed in writing, UBS is not acting as your financial adviser or fiduciary in relation to the Product. UBS generally hedges its exposure to Structured Products, although it may elect not to hedge or to partially hedge any Structured Product. UBS’s hedging activity may be conducted through transactions in the underlying asset, index or instrument or in options, futures or other derivatives related to the underlying asset, index or instrument on publicly traded markets or otherwise, and may have an impact on the price of the under-lying asset. If a transaction is cash settled, UBS will generally unwind or offset any hedge it has for such Structured Product in close proximity to the relevant valuation time or period. In some cases, this activity may affect the value of the Structured Product. Unless stated otherwise in this document, (i) this document is for information purposes only and should not be construed as an offer, personal recommendation or solicitation to purchase the Structured Product and should not be treated as giving investment advice, and (ii) the terms of any investment in the Structured Product will be exclusively subject to the detailed provisions, including risk considerations, contained in the more detailed legal documentation that relates to the Structured Product (being the confirmation, information memorandum, prospectus or other issuer documentation as relevant). UBS makes no representation or warranty relating to any information herein which is derived from independent sources. This document shall not be copied or reproduced without UBS’s prior written permission. In respect of any Structured Product that is a security, no action has been or will be taken in any jurisdiction that would permit a public offering of the Product, save where explicitly stated in the issuer documentation. The Structured Product must be sold in accordance with all applicable selling restrictions in the jurisdictions in which it is sold.
© UBS 2018. All rights reserved. UBS prohibits the forwarding of this information without the approval of UBS.
Weekly-Hits édition de 08.10.20182018-10-08T07:32:58+02:00

Weekly-Hits edition of 08.10.2018

KeyInvest Weekly Hits

Monday, 08.10.2018

Keyinvest Weekly Hits
  • Topic 1: US tax reform – US companies flourishing
  • Topic 2: Airbus/Boeing – Full-to-bursting order books

US tax reform
US companies flourishing

The US economy is buzzing. In the first quarter of 2018, the country’s gross domestic product (GDP) grew by 4.2% on an annualized basis. At the same time, the economy is more or less at full employment. One of the main drivers of this boom is the tax reform initiated at the start of the year. In December 2017, UBS launched the US Tax Reform Beneficiaries Basket to provide investors with an opportunity to participate in the benefits of the relief in a concentrated form. To date, the strategy behind the shares selected has been very successful. The PERLES (symbol: USTAXU) on the basket has gained 11.3% in value since the start of the year and is therefore outperforming the S&P 500™ index.

One of Donald Trump’s main promises that he made during his election campaign was the implementation of a large-scale tax reform. In the battle for the White House in 2016, the Republican candidate promised extensive relief for private households and businesses, true to the motto of “America first!”. Shortly before Christmas 2017 and about eleven months after taking office, Trump signed a package of laws that had been hotly contested in Washington and implemented the largest tax reform in the US in more than 30 years. This measure, one of the central elements of which was a significant reduction in corporate income tax, is now clearly taking effect. The reform is not only driving the US economy forward as a whole, it is also having a positive effect on company figures according to UBS CIO WM. The experts describe the relief as the “icing on the cake” in an already positive environment. In concrete terms, the reform could accelerate this year’s profit growth in the US by 8%. Overall, UBS CIO WM anticipates a profit increase of 18% for the current year. (Source: UBS CIO WM, «UBS House view Monthly Base», October 2018, 20.09.2018) What is certain is that the US equity market in general and the beneficiaries of the tax reform in particular are currently in strong demand among investors. While other important stock markets hardly made any headway in the first three quarters of 2018, the S&P 500™ continued its attempt to set new records. At the end of September 2018, the benchmark was up by just under 9%. Meanwhile, the US Tax Reform Beneficiaries Basket has increased in price by more than 11%.

UBS launched this selection last December, shortly before a decision had been made on the reform. The impetus to do so came from UBS Research. The in-house analysts were of the opinion at the time that the US tax reform had only been partially priced into share prices. As a result, they systematically searched for companies that could potentially profit from the reform. One of the main criterion for the composition of the basket was the influence of the reform on cash flow and its relation to the respective market capitalization. In order to ensure that the composition did not differ too much from that of the S&P 500™ index, the experts limited the number of shares per sector, resulting in a moderate overweight in companies that benefit the most.

For example, the relatively high proportion of healthcare and technology companies in the US Tax Reform Beneficiaries Basket has paid off to date. In addition to the tax reform, the friendly US consumer climate is playing into the hands of the technology sector. The same also applies to the retail sector. Kohl’s and Macy’s, among others, were considered from this sector of the economy – the shares of the two US department stores have to date risen by around 37% in 2018.

Opportunities: The tracker certificate (symbol: USTAXU) on the US Tax Reform Beneficiaries Basket is still in the first year of its seven-year term. Investors can therefore continue to be able to rely on the long-term effect of the US tax reform. The management fee for the participation product is 0.3% p.a. Any dividend payments distributed by the basket members are reinvested net in the share of the company paying out.

Risks: This product does not have capital protection. The PERLES will make a loss if the underlying basket decreases. Investors in structured products are also exposed to issuer risk, which means that the invested capital may be lost if UBS AG becomes insolvent, regardless of the performance of the underlying.

More UBS products and further information on the risks and opportunities are available at ubs.com/keyinvest.

HCA Healthcare vs. Centene vs. Humana (5 years)¹
(for illustrative purposes only; figures in %)

The three healthcare companies HCA Healthcare, Centene and Humana are among the top performers in the US Tax Reform Beneficiaries Basket to date. The upward pace of the three shares increased once again in 2018.

Source: UBS AG, Bloomberg

As of 03.10.2018

Kohl’s vs. Macy’s vs. Gap (5 years)¹

(for illustrative purposes only; figures in %)

The share prices of the two US retailers Kohl’s and Macy’s have rocketed following the introduction of the tax reform. In contrast, operational problems have put the brakes on the Gap fashion chain’s share performance.

Source: UBS AG, Bloomberg

As of: 03.10.2018

¹) Please be aware that past performance does not indicate future results.
²) The conditions of ETTs are reviewed on a yearly basis and can be adjusted with a deadline of 13 months after the announcement.

PERLES on US Tax Reform Beneficiaries Basket

Symbol USTAXU
SVSP Name Tracker-Certificate
SPVSP Code 1300
Underlying US Tax Reform Beneficiaries Basket
Ratio 1:1
Currency USD
Administration fee 0.30% p.a.
Participation 100%
Expiry 20.10.2024
Issuer UBS AG, London
Bid/Ask USD 1’135.00 / 1’145.00
 

US Tax Reform Beneficiaries Basket: Initial weighting by sector (as of: 04.12.2017)

Technology 18%
Finances 16%
Healthcare 16%
Non-basic consumer Goods 14%
Industry 12%
Basic consumer Goods 10%
Other 14%

More UBS products and further information on the risks and opportunities are available at ubs.com/keyinvest.

Source: UBS AG, Bloomberg

As of: 03.10.2018

Market overview

Index Quotation Week¹
SMI™ 9’175.21 Pkt. 1.0%
SLI™ 1488.05 Pkt. 0.0%
S&P 500™ 2’925.51 Pkt. 0.7%
Euro STOXX 50™ 3’405.48 Pkt. -0.8%
S&P™ BRIC 40 4’028.54 Pkt. -0.7%
CMCI™ Compos. 977.18 Pkt. 3.6%
Gold (troy ounce) 1’202.90 USD 0.3%

¹ Change based on the closing price of the previous day compared to the closing price a week ago.

SMI™ vs. VSMI™ 1 year

smi vs vsmi

The VSMI™ Index is calculated since 2005. It shows the volatility of the stocks within the SMI™ index. A portfolio which reacts only to changes in volatility instead of volatility itself is relevant for the calculation. Thereby, the VSMI™ methodology uses the squared volatility, known as variance, of the SMI options with remaining time to expiry of 30 days traded at the Eurex.

Source: UBS AG, Bloomberg

As of: 03.10.2018

Airbus/Boeing
Full-to-bursting order books

In the duel between the aircraft manufacturers Airbus and Boeing, the US industry leader has currently inched ahead by a nose. From January to August 2018, Boeing received net orders for 581 aircraft. In contrast, Airbus had to make do with just 219 net orders during this period. The most recent share price performance of the rivals reflects this. While the Airbus share is stagnating in the short term, the Boeing share has started the fourth quarter at a new all-time high.¹ UBS is now combining the two industry giants for an Early Redemption (ER) Worst of Kick-In GOAL (symbol: KCOADU). Investors can expect a coupon payment of 7.5% p.a. here. Meanwhile, the underlyings have a safety cushion of 40% over the two-year term.

Despite the recent slump in orders, Airbus› order book remains full to bursting. At the end of August 2018, the Group reported that it had orders for a total of 7,415 aircraft. At current production rates, production will therefore be fully utilized for almost nine years. Lastly, Airbus secured an order from Europe’s largest airline. Lufthansa converted purchase options for 27 A320 neo and A321 neo aircraft into concrete orders. Ten of the fuel-efficient aircraft from this order will go into service for SWISS. (Source: Airbus press release, 01.10.2018) At Boeing, the legendary 737 is the absolute bestseller. From January to August 2018, almost three-quarters of orders were for the classic aircraft, with the 737 MAX being most in demand. According to Boeing, never before has an airplane sold as well as this ultra-modern model in the company’s history, which stretches back for more than 100 years. The company has revealed that approximately 4,700 orders have been placed for the 737 MAX from more than 100 customers. (Source: Boeing.com) Investors will find out how well the industry leader has performed on October 24 when Boeing publishes its figures for the third quarter. Six days later, Airbus will provide an insight into the company’s latest business developments.

Opportunities: Shortly before the earnings releases, UBS will issue the ER Worst of Kick-In GOAL (symbol: KCOADU) on Airbus and Boeing. A coupon of 7.50% p.a. is available on the two shares. The barriers are set at 60% of the starting level of the two shares. As long as none of the underlyings touch or fall below this level, the product will end with a maximum return in line with the coupon. There is also the opportunity for early redemption at 100% plus the accrued coupon. The Early Redemption feature will take effect if the Airbus and Boeing shares are level with or above the initial price on one of the quarterly observation days (first date: 19.10.2019).

Risks: This product does not have capital protection. If the underlyings touch or fall below the respective Kick-In Level (barrier) and the early redemption feature does not apply, the amount repaid on the maturity date is reflecting the worst performance of the underlyings (but not more than notional value plus coupon). In this case, it is likely that losses will be incurred. Investors in structured products are also exposed to issuer risk, which means that the capital invested may be lost if UBS AG becomes insolvent, regardless of the performance of the underlying.

More UBS products and further information on the risks and opportunities are available at ubs.com/keyinvest.

Airbus vs. Boeing (5 years)¹

(for illustrative purposes only; figures in %)

Source: UBS AG, Bloomberg

As of: 03.10.2018

7.50% p.a. Early Redemption Worst of Kick-In GOAL on Airbus / Boeing

Symbol KCOADU
SVSP Name Barrier Reverse Convertible
SPVSP Code 1230 (Auto-Callable)
Underlyings Airbus / Boeing
Currency EUR
Coupon 7.50% p.a.
Kick-In Level 60.00%
Expiry 12.10.2020
Issuer UBS AG, London
Subscription until 10.10.2018, 15:00 h
 

More UBS products and further information on the risks and opportunities are available at ubs.com/keyinvest.

Source: UBS AG, Bloomberg

As of: 03.10.2018

¹) Please be aware that past performance does not indicate future results.
²) The conditions of ETTs are reviewed on a yearly basis and can be adjusted with a deadline of 13 months after the announcement.

This material has been prepared by UBS AG or one of its affiliates («UBS»). This material is for distribution only as permitted by law. It is not prepared for the needs of any specific recipient. It is published solely for information and is not a solicitation or offer to buy or sell any securities or related financial instruments (“Instruments”). UBS makes no representation or warranty, either express or implied, on the completeness or reliability of the information contained in this document (“Information”) except that concerning UBS AG and its affiliates. The Information should not be regarded by recipients as a substitute for using their own judgment. Any opinions expressed in this material may change without notice and may be contrary to opinions expressed by other business areas of UBS as a result of using different assumptions or criteria. UBS is under no obligation to update the Information. UBS, its officers, employees or clients may have or have had an interest in the Instruments and may at any time transact in them. UBS may have or have had a relationship with entities referred to in the Information. Neither UBS nor any of its affiliates, or their officers or employees, accepts any liability for any loss arising from use of the Information. This presentation is not a basis for entering into a transaction. Any transaction between you and UBS will be subject to the detailed provisions of the term sheet, confirmation or electronic matching systems relating to that transaction. Clients wishing to effect transactions should contact their local sales representative.
This information is communicated by UBS AG and/or its affiliates («UBS»). * (see below) UBS may from time to time, as principal or agent, have positions in, or may buy or sell, or make a market in any securities, currencies, financial instruments or other assets underlying the product to which this website relates (the «Structured Product»). UBS may provide investment banking and other services to and/or have officers who serve as directors of the companies referred to in this website. UBS’s trading and/or hedging activities related to the Structured Product may have an impact on the price of the underlying asset and may affect the likelihood that any relevant barrier or relevant trigger event is crossed or triggered. UBS has policies and procedures designed to minimise the risk that officers and employees are influenced by any conflicting interest or duty and that confidential information is improperly disclosed or made available. UBS may pay or receive brokerage or retrocession fees in connection with the Structured Product described herein. In respect of any Structured Product that is a security, UBS may, in certain circumstances, sell the Structured Product to dealers and other financial institutions at a discount to the issue price or rebate to them for their own account some proportion of the issue price. Further information is available on request. Structured Products are complex and may involve a high risk of loss. Prior to purchasing the Structured Product you should consult with your own legal, regulatory, tax, financial and accounting advisors to the extent you consider it necessary, and make your own investment, hedging and trading decisions (including decisions regarding the suitability of the Structured Product) based upon your own judgement and advice from those advisers you consider necessary. Save as otherwise expressly agreed in writing, UBS is not acting as your financial adviser or fiduciary in relation to the Product. UBS generally hedges its exposure to Structured Products, although it may elect not to hedge or to partially hedge any Structured Product. UBS’s hedging activity may be conducted through transactions in the underlying asset, index or instrument or in options, futures or other derivatives related to the underlying asset, index or instrument on publicly traded markets or otherwise, and may have an impact on the price of the under-lying asset. If a transaction is cash settled, UBS will generally unwind or offset any hedge it has for such Structured Product in close proximity to the relevant valuation time or period. In some cases, this activity may affect the value of the Structured Product. Unless stated otherwise in this document, (i) this document is for information purposes only and should not be construed as an offer, personal recommendation or solicitation to purchase the Structured Product and should not be treated as giving investment advice, and (ii) the terms of any investment in the Structured Product will be exclusively subject to the detailed provisions, including risk considerations, contained in the more detailed legal documentation that relates to the Structured Product (being the confirmation, information memorandum, prospectus or other issuer documentation as relevant). UBS makes no representation or warranty relating to any information herein which is derived from independent sources. This document shall not be copied or reproduced without UBS’s prior written permission. In respect of any Structured Product that is a security, no action has been or will be taken in any jurisdiction that would permit a public offering of the Product, save where explicitly stated in the issuer documentation. The Structured Product must be sold in accordance with all applicable selling restrictions in the jurisdictions in which it is sold.
© UBS 2018. All rights reserved. UBS prohibits the forwarding of this information without the approval of UBS.
Weekly-Hits edition of 08.10.20182018-10-08T07:06:13+02:00

Weekly-Hits édition de 28.09.2018

KeyInvest Weekly Hits

Vendredi, 28.09.2018

dax
  • Thème 1: Allemagne - L’automne sera chaud
  • Thème 2: Ferrari / Porsche - Un nouvel éclat pour les voitures de luxe

Allemagne
L’automne sera chaud

Précisément pour l’année de son 30e anniversaire, l’indice DAX™ a perdu la cadence. Depuis début 2018, l’indice DAX™ (Deutscher Aktienindex) lancé le 1er juillet 1988 affiche une baisse de 4,4%.¹ Comme sur d’autres places boursières également, l’inflation du conflit commercial constitue le frein le plus important pour le marché des actions allemand. Toutefois, l’indice ifo du climat des affaires actuel révèle que le moral reste relativement élevé au sein de l’économie allemande, en dépit de tous les facteurs d’incertitude. Avec un ETT (symbole : ETDAX), les investisseurs peuvent profiter de la faiblesse actuelle du cours de l’indice DAX™ pour un premier placement. Alors que le produit de participation est directement couplé aux hausses et aux baisses des 30 Large Caps, le nouveau Worst of Kick-In GOAL (symbole : KCMSDU) vise une évolution relativement stable de Bayer, SAP et Volkswagen. Le Trio DAX™ permet un coupon de 6,50% p.a. Cette opportunité de rendement est couplée à une marge de sécurité de 40%.

Chaque mois, l’institut ifo de Munich interroge quelque 9000 managers sur la situation actuelle et sur leurs prévisions pour les six prochains mois. L’indice du climat des affaires tiré de cette enquête compte parmi les indicateurs avancés les plus importants de l’économie allemande. En septembre, le baromètre s’est légèrement assombri, passant à 103,7 points contre 103,9 points au mois précédent. Toutefois, d’un point de vue historique, il se maintient à un niveau élevé. Clemens Fuest, président de l’institut ifo, commente ainsi les résultats actuels : « L’économie allemande reste stable, même si l’incertitude s’accroît ». (Source : Institut ifo, communiqué de presse, 24.09.2018)

A la bourse de Francfort, l’inflation du conflit douanier entre les Etats-Unis et la Chine pèse toujours sur le moral des investisseurs. S’ajoute à cela une situation politique instable inhabituelle pour l’Allemagne. Toutefois, la grande coalition CDU, CSU et SPD souhaite désormais se concentrer sur le travail objectif après les récentes querelles concernant le président de l’Office fédéral de la protection de la Constitution Hans-Georg Maassen. Les élections aux assemblées parlementaires de Bavière et de la Hesse qui auront lieu les 14 et 28 octobre donneront une indication à ce sujet. Outre les deux votations, les investisseurs DAX™ pourraient surtout observer la saison sous revue au cours des semaines à venir. Il apparaîtra dans ce contexte si et dans quelle mesure le nouveau protectionnisme influence les affaires des grands groupes allemands actifs dans l’exportation.

Opportunités: si les chiffres disponibles réveillent le DAX™ de sa léthargie récente, l’ETT (symbole : ETDAX) pourrait constituer un instrument de placement intéressant. Ce produit Open End reproduit l’indice directeur en proportion de 10 à 1. Dans ce contexte, l’investisseur profite également des conditions de participation aux bénéfices attrayantes des Large Caps allemandes, les dividendes étant réinvestis net. Comme souvent pour ce type de structure aucune commission de gestion n’est appliquée.² D’ailleurs, traditionnellement SAP ouvre la saison sous revue dans le DAX. Ce groupe informatique présentera ses résultats trimestriels le 18 octobre. Avec Bayer et Volkswagen, l’action SAP sert de sous-jacent pour un nouveau Worst of Kick-In GOAL (symbole : KCMSDU). Les investisseurs peuvent prévoir ici un versement ferme de coupon d’un montant de 6,50% p.a.
Si la condition suivante est réalisée, ils se voient en outre rembourser l’intégralité du nominal à l’échéance : aucune des trois actions n’atteint ou ne dépasse la barrière inférieure de 60% du niveau initial.

Risques: il n’existe aucune protection du capital pour les produits présentés. Avec un ETT, dès que l’indice sous-jacent tombe en-dessous du prix d’entrée, des pertes se produisent. Si, pendant la durée de l’investissement, l’un des sous-jacents du Worst of Kick-In GOAL atteint une seule fois la barrière respective («Kick-In Level») ou est inférieur à celle-ci, le remboursement par amortissement en espèces à l’échéance est basé sur la performance la plus faible (base Strike) du trio (au maximum toutefois à la valeur nominale majorée du coupon). Dans un tel cas, des pertes sont probables. De plus, avec les produits structurés, l’investisseur supporte le risque d’émetteur. Cela signifie qu’en cas d’insolvabilité d’UBS SA, le capital investi peut être perdu, indépendamment de l’évolution des sous-jacents.

Vous trouverez davantage de produits UBS et des informations sur les opportunités et les risques à l’adresse ubs.com/keyinvest.

DAX™ (5 ans)¹

Une consolidation à un niveau élevé : depuis plus d’un an, le DAX™ évolue latéralement. Pendant ce temps, le secteur autour des 12 000 points s’est cristallisé comme un soutien à l’indice.

Source: UBS AG, Bloomberg

Valeurs du: 27.09.2018

Bayer vs. SAP vs. Volkswagen (5 ans)¹

Trois actions, deux orientation : alors que Bayer et Volkswagen enregistrent des signaux négatifs à cinq ans, SAP, le poids lourd du DAX™ a nettement fait progressé sa valeur boursière.

Source: UBS AG, Bloomberg

Valeurs du: 27.09.2018

¹) La performance passée n’indique pas les résultats futures.
²) Les condition des ETTs sont vérifiés annuellement et peuvent être ajustées avec un délai de 13 mois après la publication.

ETT sur DAX™

Symbol ETDAX
SVSP Name Tracker certificat
SPVSP Code 1300
Sous-jacent DAX™
Rapport de souscription 10:1
Devise EUR
Frais de gestion 0.00% p.a.
Participation 100%
Echéance Open End
Émetteur UBS AG, London
Bid/Ask EUR 1’235.00 / 1’241.00
 

6.50% p.a. Worst of Kick-In GOAL sur Bayer / SAP / Volkswagen

Symbol KCMSDU
SVSP Name Barrier Reverse Convertible
SPVSP Code 1230
Sous-jacent Bayer / SAP / Volkswagen VZ
Devise EUR
Coupon 6.50% p.a.
Kick-In Level 60.00%
Echéance 03.04.2020
Émetteur UBS AG, London
Date de fixation du prix 03.10.2018, 15:00 h
 

Vous trouverez davantage de produits UBS et des informations sur les opportunités et les risques à l’adresse ubs.com/keyinvest.

Source: UBS AG, Bloomberg

Valeurs du: 27.09.2018

Apérçu du marché

Index Citation Semaine¹
SMI™ 9’080.14 1.6%
SLI™ 1’488.24 1.6%
S&P 500™ 2’905.97 -0.1%
Euro STOXX 50™ 3’433.15 1.9%
S&P™ BRIC 40 4’056.94 2.1%
CMCI™ Compos. 943.22 1.4%
Gold (once troy) 1’199.10 -0.8%

¹ Changement basé sur le cours de clôture du jour précédent par rapport au cours de clôture de la semaine dernière.

SMI™ vs. VSMI™ 1 année

L’index VSMI™ est calculé depuis 2005. Il affiche la volatilité des actions inclus dans le SMI™ index. Pour la calculation, un portefeuille est utilisé qui ne réagit qu’au variations de la volatilité au lieu des variations des prix. En le faisant, la méthodologie du VSMI™ utilise la volatilité carré, connu sous le terme variance, des options sur le SMI avec 30 jours jusqu’à l’échéance négociées à la Bourse Eurex.

Source: UBS AG, Bloomberg

Valeurs du: 27.09.2018

Ferrari / Porsche
Un nouvel éclat pour les voitures de luxe

Les événements se précipitent actuellement dans le segment de la voiture de sport : le constructeur de véhicules de luxe Ferrari souhaite lancer au total 15 nouveaux modèles sur le marché d’ici 2022. Quelque 60% des véhicules devront alors être équipés d’un moteur hybride. La motorisation alternative constitue également un thème important pour Porsche. Le groupe a été le premier constructeur automobile à faire connaître sa sortie du Diesel. Il se concentre désormais totalement sur les véhicules à essence, hybrides et électriques. Les investisseurs ont la possibilité d’intégrer les deux titres automobiles dans leur dépôt. Le Kick-In GOAL en souscription (symbole : KCOIDU) est pourvu d’un coupon intéressant de 8,00% p.a., et propose une marge de sécurité de 30%.

Le moteur traditionnel à combustion disparaît progressivement. Désormais, l’énergie électrique s’est également emparée définitivement du secteur des voitures de sport. Porsche bannit le Diesel de sa gamme de production et intensifie en revanche la mobilité hybride et électrique. D’ici 2022, plus de six milliards d’euros seront consacrés à ces technologies. En 2025 déjà, un véhicule neuf de Porsche sur deux devrait être équipé d’un moteur électrique, soit hybride, soit totalement électrique. Le groupe de tradition italien Ferrari suit la même voie. Lors de la récente présentation du nouveau plan de développement à moyen terme à Maranello, le PDG du groupe Louis Camilleri a dévoilé un feu d’artifice de modèles. Entre 2019 et 2022, 15 nouveaux modèles et variantes de modèles sont prévus dans les domaines Sport, GT et Special Series. On y trouvera aussi, après de longues hésitations, un véhicule tout terrain sportif. Cette offensive va donc élargir encore la gamme de produits actuelle. En 2022, quelque 60% des Ferrari seront des modèles hybrides. S’agissant des bénéfices, la tendance est à l’optimisme. On prévoit pour 2022 une marge opérationnelle de 38% pour le groupe. Elle s’établissait à 31,9% au deuxième trimestre 2018.

Opportunités: les personnes souhaitant intégrer les deux fabricants de voitures de luxe dans leur dépôt pourraient considérer le Worst of Kick-In GOAL (symbole : KCOIDU). Cette nouvelle émission est tout à fait honorable. Le produit en souscription dispose d’un coupon de 8,00% p.a. ainsi que d’une marge de sécurité initiale de 30%. Tant que ni Ferrari ni
Porsche n’atteint ou ne passe sous la barrière de 70% du niveau initial, le rendement maximal est obtenu. Le produit émis en francs suisses est couvert contre les risques de change. L’échéance est de précisément un an.

Risques: les Kick-In GOALS ne bénéficient d’aucune protection du capital. Si, pendant la durée de l’investissement, l’un des sous-jacents atteint une seule fois la barrière respective («Kick-In Level») ou est inférieur à celle-ci, le remboursement par amortissement en espèces à l’échéance est basé sur la performance la plus faible (base Strike) du duo (au maximum toutefois à la valeur nominale majorée du coupon). Dans un tel cas, des pertes sont probables. Par ailleurs, avec les produits structurés, l’investisseur supporte le risque d’émetteur. Cela signifie qu’en cas d’insolvabilité d’UBS SA, le capital investi peut être perdu, indépendamment de l’évolution du sous-jacent.

Vous trouverez davantage de produits UBS et des informations sur les opportunités et les risques à l’adresse ubs.com/keyinvest.

Ferrari vs. Porsche (depuis 04.01.2016, Start Ferrari-Listing à Milan)¹

Source: UBS AG, Bloomberg

Valeurs du: 27.09.2018

8.00% p.a. Worst of Kick-In GOAL sur Porsche / Ferrari

Symbol KCOIDU
SVSP Name Barrier Reverse Convertible
SPVSP Code 1230
Sous-jacent Ferrari / Porsche
Devise CHF (Quanto)
Coupon 8.00% p.a.
Kick-In Level 70.00%
Echéance 10.10.2019
Émetteur UBS AG, London
Date de fixation du prix 10.10.2018, 15:00 h
 

Vous trouverez davantage de produits UBS et des informations sur les opportunités et les risques à l’adresse ubs.com/keyinvest.

Source: UBS AG, Bloomberg

Valeurs du: 27.09.2018

¹) La performance passée n’indique pas les résultats futures.
²) Les condition des ETTs sont vérifiés annuellement et peuvent être ajustées avec un délai de 13 mois après la publication.

This material has been prepared by UBS AG or one of its affiliates («UBS»). This material is for distribution only as permitted by law. It is not prepared for the needs of any specific recipient. It is published solely for information and is not a solicitation or offer to buy or sell any securities or related financial instruments (“Instruments”). UBS makes no representation or warranty, either express or implied, on the completeness or reliability of the information contained in this document (“Information”) except that concerning UBS AG and its affiliates. The Information should not be regarded by recipients as a substitute for using their own judgment. Any opinions expressed in this material may change without notice and may be contrary to opinions expressed by other business areas of UBS as a result of using different assumptions or criteria. UBS is under no obligation to update the Information. UBS, its officers, employees or clients may have or have had an interest in the Instruments and may at any time transact in them. UBS may have or have had a relationship with entities referred to in the Information. Neither UBS nor any of its affiliates, or their officers or employees, accepts any liability for any loss arising from use of the Information. This presentation is not a basis for entering into a transaction. Any transaction between you and UBS will be subject to the detailed provisions of the term sheet, confirmation or electronic matching systems relating to that transaction. Clients wishing to effect transactions should contact their local sales representative.
This information is communicated by UBS AG and/or its affiliates («UBS»). * (see below) UBS may from time to time, as principal or agent, have positions in, or may buy or sell, or make a market in any securities, currencies, financial instruments or other assets underlying the product to which this website relates (the «Structured Product»). UBS may provide investment banking and other services to and/or have officers who serve as directors of the companies referred to in this website. UBS’s trading and/or hedging activities related to the Structured Product may have an impact on the price of the underlying asset and may affect the likelihood that any relevant barrier or relevant trigger event is crossed or triggered. UBS has policies and procedures designed to minimise the risk that officers and employees are influenced by any conflicting interest or duty and that confidential information is improperly disclosed or made available. UBS may pay or receive brokerage or retrocession fees in connection with the Structured Product described herein. In respect of any Structured Product that is a security, UBS may, in certain circumstances, sell the Structured Product to dealers and other financial institutions at a discount to the issue price or rebate to them for their own account some proportion of the issue price. Further information is available on request. Structured Products are complex and may involve a high risk of loss. Prior to purchasing the Structured Product you should consult with your own legal, regulatory, tax, financial and accounting advisors to the extent you consider it necessary, and make your own investment, hedging and trading decisions (including decisions regarding the suitability of the Structured Product) based upon your own judgement and advice from those advisers you consider necessary. Save as otherwise expressly agreed in writing, UBS is not acting as your financial adviser or fiduciary in relation to the Product. UBS generally hedges its exposure to Structured Products, although it may elect not to hedge or to partially hedge any Structured Product. UBS’s hedging activity may be conducted through transactions in the underlying asset, index or instrument or in options, futures or other derivatives related to the underlying asset, index or instrument on publicly traded markets or otherwise, and may have an impact on the price of the under-lying asset. If a transaction is cash settled, UBS will generally unwind or offset any hedge it has for such Structured Product in close proximity to the relevant valuation time or period. In some cases, this activity may affect the value of the Structured Product. Unless stated otherwise in this document, (i) this document is for information purposes only and should not be construed as an offer, personal recommendation or solicitation to purchase the Structured Product and should not be treated as giving investment advice, and (ii) the terms of any investment in the Structured Product will be exclusively subject to the detailed provisions, including risk considerations, contained in the more detailed legal documentation that relates to the Structured Product (being the confirmation, information memorandum, prospectus or other issuer documentation as relevant). UBS makes no representation or warranty relating to any information herein which is derived from independent sources. This document shall not be copied or reproduced without UBS’s prior written permission. In respect of any Structured Product that is a security, no action has been or will be taken in any jurisdiction that would permit a public offering of the Product, save where explicitly stated in the issuer documentation. The Structured Product must be sold in accordance with all applicable selling restrictions in the jurisdictions in which it is sold.
© UBS 2018. All rights reserved. UBS prohibits the forwarding of this information without the approval of UBS.
Weekly-Hits édition de 28.09.20182018-10-01T06:22:52+02:00

Weekly-Hits edition of 28.09.2018

KeyInvest Weekly Hits

Friday, 28.09.2018

dax
  • Topic 1: Germany – A warm fall
  • Topic 2: Ferrari/Porsche – Luxury car bodies in new splendor

Germany
A warm fall

Just as it enters the year of its 30th anniversary, the DAX™ has been thrown out of step. Since the start of the year, the Deutscher Aktienindex™, launched on July 1, 1988, has recorded a negative performance of 4.4%.¹ As is the case on other stock exchanges, the simmering trade conflict is regarded as the main source of friction for the German stock market. Nevertheless, the current ifo Business Climate Index shows that the mood within the German economy remains at a comparatively high level despite all of the factors contributing to the uncertainty. With an ETT (symbol: ETDAX), investors can use the current weakness in the DAX™ to enter the market. While the participation product is directly linked to the fluctuating performances of 30 large caps, the aim of the new Worst of Kick-In GOAL on Bayer, SAP and Volkswagen (symbol: KCMSDU) is to achieve a relatively stable performance. The DAX™ trio allow a coupon of 6.50 percent p.a. This return opportunity is linked to a 40% safety buffer.

Every month, the Munich-based ifo Institute asks around 9,000 managers about the current situation on the markets and their expectations for the next six months. This survey helps form the Business Climate Index, which is one of the most important early indicators for the German economy. Although the barometer became slightly gloomier in September, falling to 103.7 points after totaling 103.9 points in the previous month, the Index still remained at a historically high level. “The German economy is stable, even if there is increasing uncertainty,” commented Clemens Fuest, President of the ifo Institute, on the latest results. (Source: ifo Institute press release, 24.09.2018)

The customs dispute between the US and China that continues to simmer is weighing heavily on the mood on the Frankfurt Stock Exchange. Added to this is an instable political situation, which is unusual for Germany. Nevertheless, the Grand Coalition of the CDU, CSU and SPD would now like to focus on the business at hand after the recent quarrels regarding Hans-Georg Maassen, former President of the Federal Office for the Protection of the Constitution. The German regional elections in Bavaria and Hesse on October 14 and 28, respectively, could be indicatory in this respect. In addition to the two polls, DAX™ investors are likely to keep a close eye on the reporting season over the coming weeks, as this will show whether and to what extent the protectionism that is emerging worldwide is having an impact on the business of the major export-oriented German corporations.

Opportunities: Should the results of the elections cure the DAX™ of its recent lethargy, the ETT (symbol: ETDAX) would be an effective investment instrument. The open-end product tracks the key index with a conversion ratio of 10:1. Investors also benefit from the attractive profit sharing schemes of the German large caps, with dividends being reinvested in net terms. No management fees are typically incurred for this structure.² SAP traditionally kicks off the reporting season on the DAX, with the software group presenting its quarterly figures on October 18. Together with those of Bayer and Volkswagen, the SAP share serves as the underlyings for a new Worst of Kick-In GOAL (symbol: KCMSDU). Investors can make concrete plans here thanks to an annual coupon payment of 6.50%. If none of the shares fall level with or below the barrier of 60% of the initial fixings, investors will also receive their nominal amount back in full at the end of the term.

Risks: These products do not have capital protection. The ETT will make a loss if the underlying index falls below the initial price. If the underlyings of the Worst of Kick-In GOAL touch or fall below the respective Kick-In Level (barrier), the amount repaid on the maturity date is reflecting the worst performance of the underlyings (but not more than notional value plus coupon). In this case, it is likely that losses will be incurred. Investors in structured products are also exposed to issuer risk, which means that the capital invested may be lost if UBS AG becomes insolvent, regardless of the performance of the underlying.

More UBS products and further information on the risks and opportunities are available at ubs.com/keyinvest.

DAX™ (5 years)¹

Consolidation at a high level: The DAX™ has been trending sideward for more than a year. During this time, the area has emerged as a support level for the benchmark at around 12,000 points.

Source: UBS AG, Bloomberg

As of 27.09.2018

Bayer vs. SAP vs. Volkswagen (5 years)¹

Three equities, two directions: While Bayer and Volkswagen have posted a negative performance over the last five years, the DAX™ heavyweight SAP was able to significantly increase its market capitalization.

Source: UBS AG, Bloomberg

As of: 27.09.2018

¹) Please be aware that past performance does not indicate future results.
²) The conditions of ETTs are reviewed on a yearly basis and can be adjusted with a deadline of 13 months after the announcement.

ETT on DAX™

Symbol ETDAX
SVSP Name Tracker-Certificate
SPVSP Code 1300
Underlying DAX™
Ratio 10:1
Currency EUR
Administration fee 0.00% p.a.
Participation 100%
Expiry Open End
Issuer UBS AG, London
Bid/Ask EUR 1’235.00 / 1’241.00
 

6.50% p.a. Worst of Kick-In GOAL auf Bayer / SAP / Volkswagen

Symbol KCMSDU
SVSP Name Barrier Reverse Convertible
SPVSP Code 1230
Underlying Bayer / SAP / Volkswagen VZ
Currency EUR
Coupon 6.50% p.a.
Kick-In Level 60.00%
Expiry 03.04.2020
Issuer UBS AG, London
Subscription until 03.10.2018, 15:00 h
 

More UBS products and further information on the risks and opportunities are available at ubs.com/keyinvest.

Source: UBS AG, Bloomberg

As of: 27.09.2018

Market overview

Index Quotation Week¹
SMI™ 9’080.14 1.6%
SLI™ 1’488.24 1.6%
S&P 500™ 2’905.97 -0.1%
Euro STOXX 50™ 3’433.15 1.9%
S&P™ BRIC 40 4’056.94 2.1%
CMCI™ Compos. 943.22 1.4%
Gold (troy ounce) 1’199.10 -0.8%

¹ Change based on the closing price of the previous day compared to the closing price a week ago.

SMI™ vs. VSMI™ 1 year

smi vs vsmi

The VSMI™ Index is calculated since 2005. It shows the volatility of the stocks within the SMI™ index. A portfolio which reacts only to changes in volatility instead of volatility itself is relevant for the calculation. Thereby, the VSMI™ methodology uses the squared volatility, known as variance, of the SMI options with remaining time to expiry of 30 days traded at the Eurex.

Source: UBS AG, Bloomberg

As of: 27.09.2018

Ferrari/Porsche
Luxury car bodies in new splendor

The events in the sports car segment are coming thick and fast at the moment, as luxury manufacturer Ferrari wants to place 15 new models on the market by 2022. Their aim by this point in time is for some 60% of their cars to come equipped with a hybrid engine. Alternative engines are also a hot topic at rivals Porsche. The company was the first German car maker to announce its intention to withdraw from the diesel market. It now focuses solely on gasoline engines, hybrid models and electric vehicles. Investors have the option of including both of the car stocks in their portfolio. The new Worst of Kick-In GOAL (symbol: KCOIDU) in subscription has an attractive annual coupon of 8% and offers a safety buffer of 30%.

The traditional combustion engine is increasingly becoming obsolete. Electric engines are now also making waves in the sports car industry. Porsche has removed diesel engines from its product range and increased its focus in the areas of hybrid and electric mobility. It is estimated that more than EUR 6 billion will be pumped into these technologies by 2022. As early as 2025, every second new Porsche vehicle could be electrically powered, be it via a hybrid engine or a completely electric engine. The long-established Italian company Ferrari is also following this path. At its recent presentation of the new medium-term development plan in Maranello, CEO Louis Camilleri announced a plethora of new models – with 15 new models and model variants being planned to be released in the three areas of Sport, GT and Special Series between 2019 and 2022. This will also include a sporty all-terrain vehicle, which has suffered long delays. The aim of this offensive push is to further diversify the current product range. By 2022, some 60% of the Ferraris produced will be hybrid models. This should also see profits increasing further. The Group’s operating margin is expected to reach 38% in 2022, after totaling 31.9% in the second quarter of 2018.

Opportunities: Should any investors want the two luxury car body manufacturers to be part of their portfolio as a pair, they would be advised to take a look at the Worst of Kick-In GOAL (symbol: KCOIDU). The configuration of this new issue is very impressive – The product is in subscription and has an annual coupon of 8% as well as an initial risk buffer of 30%. Provided that neither the Ferrari share nor the Porsche share fall level with or below the barrier of 70% of the initial fixing level, the maximum return will be paid out. The product issued in Swiss francs includes currency hedging. The security matures after exactly one year.

Risks: This product does not have capital protection. If the underlyings touch or fall below the respective Kick-In Level (barrier), the amount repaid on the maturity date is reflecting the worst performance of the underlyings (but not more than notional value plus coupon). In this case, it is likely that losses will be incurred. Investors in structured products are also exposed to issuer risk, which means that the capital invested may be lost if UBS AG becomes insolvent, regardless of the performance of the underlying.

More UBS products and further information on the risks and opportunities are available at ubs.com/keyinvest.

Ferrari vs. Porsche (since 04.01.2016, Start Ferrari-Listing in Mailand)¹

Source: UBS AG, Bloomberg

As of: 27.09.2018

8.00% p.a. Worst of Kick-In GOAL on Porsche / Ferrari

Symbol KCOIDU
SVSP Name Barrier Reverse Convertible
SPVSP Code 1230
Underlyings Ferrari / Porsche
Currency CHF (Quanto)
Coupon 8.00% p.a.
Kick-In Level 70.00%
Expiry 10.10.2019
Issuer UBS AG, London
Subscription until 10.10.2018, 15:00 h
 

More UBS products and further information on the risks and opportunities are available at ubs.com/keyinvest.

Source: UBS AG, Bloomberg

As of: 27.09.2018

¹) Please be aware that past performance does not indicate future results.
²) The conditions of ETTs are reviewed on a yearly basis and can be adjusted with a deadline of 13 months after the announcement.

This material has been prepared by UBS AG or one of its affiliates («UBS»). This material is for distribution only as permitted by law. It is not prepared for the needs of any specific recipient. It is published solely for information and is not a solicitation or offer to buy or sell any securities or related financial instruments (“Instruments”). UBS makes no representation or warranty, either express or implied, on the completeness or reliability of the information contained in this document (“Information”) except that concerning UBS AG and its affiliates. The Information should not be regarded by recipients as a substitute for using their own judgment. Any opinions expressed in this material may change without notice and may be contrary to opinions expressed by other business areas of UBS as a result of using different assumptions or criteria. UBS is under no obligation to update the Information. UBS, its officers, employees or clients may have or have had an interest in the Instruments and may at any time transact in them. UBS may have or have had a relationship with entities referred to in the Information. Neither UBS nor any of its affiliates, or their officers or employees, accepts any liability for any loss arising from use of the Information. This presentation is not a basis for entering into a transaction. Any transaction between you and UBS will be subject to the detailed provisions of the term sheet, confirmation or electronic matching systems relating to that transaction. Clients wishing to effect transactions should contact their local sales representative.
This information is communicated by UBS AG and/or its affiliates («UBS»). * (see below) UBS may from time to time, as principal or agent, have positions in, or may buy or sell, or make a market in any securities, currencies, financial instruments or other assets underlying the product to which this website relates (the «Structured Product»). UBS may provide investment banking and other services to and/or have officers who serve as directors of the companies referred to in this website. UBS’s trading and/or hedging activities related to the Structured Product may have an impact on the price of the underlying asset and may affect the likelihood that any relevant barrier or relevant trigger event is crossed or triggered. UBS has policies and procedures designed to minimise the risk that officers and employees are influenced by any conflicting interest or duty and that confidential information is improperly disclosed or made available. UBS may pay or receive brokerage or retrocession fees in connection with the Structured Product described herein. In respect of any Structured Product that is a security, UBS may, in certain circumstances, sell the Structured Product to dealers and other financial institutions at a discount to the issue price or rebate to them for their own account some proportion of the issue price. Further information is available on request. Structured Products are complex and may involve a high risk of loss. Prior to purchasing the Structured Product you should consult with your own legal, regulatory, tax, financial and accounting advisors to the extent you consider it necessary, and make your own investment, hedging and trading decisions (including decisions regarding the suitability of the Structured Product) based upon your own judgement and advice from those advisers you consider necessary. Save as otherwise expressly agreed in writing, UBS is not acting as your financial adviser or fiduciary in relation to the Product. UBS generally hedges its exposure to Structured Products, although it may elect not to hedge or to partially hedge any Structured Product. UBS’s hedging activity may be conducted through transactions in the underlying asset, index or instrument or in options, futures or other derivatives related to the underlying asset, index or instrument on publicly traded markets or otherwise, and may have an impact on the price of the under-lying asset. If a transaction is cash settled, UBS will generally unwind or offset any hedge it has for such Structured Product in close proximity to the relevant valuation time or period. In some cases, this activity may affect the value of the Structured Product. Unless stated otherwise in this document, (i) this document is for information purposes only and should not be construed as an offer, personal recommendation or solicitation to purchase the Structured Product and should not be treated as giving investment advice, and (ii) the terms of any investment in the Structured Product will be exclusively subject to the detailed provisions, including risk considerations, contained in the more detailed legal documentation that relates to the Structured Product (being the confirmation, information memorandum, prospectus or other issuer documentation as relevant). UBS makes no representation or warranty relating to any information herein which is derived from independent sources. This document shall not be copied or reproduced without UBS’s prior written permission. In respect of any Structured Product that is a security, no action has been or will be taken in any jurisdiction that would permit a public offering of the Product, save where explicitly stated in the issuer documentation. The Structured Product must be sold in accordance with all applicable selling restrictions in the jurisdictions in which it is sold.
© UBS 2018. All rights reserved. UBS prohibits the forwarding of this information without the approval of UBS.
Weekly-Hits edition of 28.09.20182018-09-28T11:34:20+02:00
Go to Top